{"item_id": "8a0ad329fde0acfb", "question": "For a derivative transaction that is mapped to the commodity risk category and has more than one material risk driver (including transactions referred to in Article 277(3)), how must an institution determine (i) whether the transaction is mapped once or multiple times across risk categories, and (ii) which risk driver basis is then used to assign the transaction to a hedging set within the commodity risk category?", "gold_answer": "An institution must first decide how many risk-category mappings are required for the derivative transaction, and then—once the transaction is mapped to the commodity risk category—assign it to a commodity hedging set using the appropriate risk-driver basis. [#SRC:820ffbb74005c855] For derivatives with more than one material risk driver, the institution must map the transaction to more than one risk category as a derogation from paragraph 2. [#TGT:28d975e9bccdd9ad] If all material risk drivers fall within a single risk category, the transaction is mapped only once to that category, using the most material of those risk drivers as the basis for that single mapping. [#TGT:28d975e9bccdd9ad] If the material risk drivers span different risk categories, the transaction is mapped once to each relevant risk category for which it has at least one material risk driver, and the mapping within each category is based on the most material risk driver in that category. [#TGT:28d975e9bccdd9ad] After the transaction is mapped to the commodity risk category (including for transactions referred to in Article 277(3)), it must be assigned to one of the commodity hedging sets based on the nature of its primary risk driver, or—where applicable—the most material risk driver in the commodity risk category. [#SRC:820ffbb74005c855]", "source_text": "(e) transactions mapped to the commodity risk category shall be assigned to one of the following hedging sets on the basis of the nature of their primary risk driver or the most material risk driver in the given risk category for transactions referred to in Article 277(3) :", "target_text": "By way of derogation from paragraph 2 , institutions shall map derivative transactions that have more than one material risk driver to more than one risk category. Where all the material risk drivers of one of those transactions belong to the same risk category, institutions shall only be required to map that transaction once to that risk category on the basis of the most material of those risk drivers. Where the material risk drivers of one of those transactions belong to different risk categories, institutions shall map that transaction once to each risk category for which the transaction has at least one material risk driver, on the basis of the most material of the risk drivers in that risk category.", "source_passage_id": "820ffbb74005c855", "target_passage_id": "28d975e9bccdd9ad", "method": "DPEL", "persona": "professional"}
{"item_id": "6793d102b96863d0", "question": "If senior management is putting names to the model risk jobs (for model owners, model users, and control/compliance) under the board’s documented model risk framework, what extra thing should the firm do when those jobs sit in senior management functions, and how does that fit with the board and senior management’s duty to challenge model outputs?", "gold_answer": "When the firm is allocating model risk management responsibilities into senior management functions, it should not only follow the board’s documented framework and senior management’s role in running it, but also take into account the relevant prescribed responsibilities in the PRA Rulebook’s ‘Allocation of Responsibilities’ 4.1 or 5.2. [#SRC:d4070cd7428fcd33] [#TGT:51ea2b168d63b6d3] The board of directors should set up and document the framework for managing model risk, and senior management is responsible for executing and maintaining it, including assigning roles and responsibilities to model owners, model users, and control and compliance functions. [#SRC:d4070cd7428fcd33] Because the Target text specifically addresses assignments to senior management functions, the firm should consider the prescribed responsibilities in the cited ‘Allocation of Responsibilities’ sections when making those allocations. [#TGT:51ea2b168d63b6d3] Those allocations should also support the expectation that the board of directors and senior management provide challenge to model outputs and understand model capabilities, limitations, and the impact of model uncertainty for the most material models and aggregate outputs, so the assigned responsibilities enable that challenge and understanding in practice. [#SRC:d4070cd7428fcd33]", "source_text": "P2.1 Board of directors and senior management responsibility: 5 The board of directors should establish a framework for the management of model risk and this should be adequately documented. Senior management is responsible for the execution and maintenance of the framework and should designate the roles and responsibilities for the framework to model owners, model users, and control and compliance functions. 6 The board of directors and senior management are expected to provide challenge to model outputs and understand model capabilities, the model limitations, and the potential impact of model uncertainty for the most material models and the aggregate outputs.", "target_text": "5. When assigning the responsibilities of the management of model risk to senior management functions, firms should consider the relevant prescribed responsibilities in ‘Allocation of Responsibilities’ 4.1 or 5.2 in the PRA Rulebook.", "source_passage_id": "d4070cd7428fcd33", "target_passage_id": "51ea2b168d63b6d3", "method": "DPEL", "persona": "basic"}
{"item_id": "36e4f445e81aa78a", "question": "Who has to appoint the compliance officer, and how does that role connect to the rule that senior management must get written reports (at least once a year) that say whether fixes were made when problems were found?", "gold_answer": "The management body must appoint a compliance officer, and that compliance officer must be responsible for the compliance function and for any compliance reporting required for the firm’s obligations under the regulatory system and General Organisational Requirements 4.7. [#SRC:08b491dc52b89657] Separately, the firm must make sure its senior management receive written reports frequently and at least annually on the matters covered by the Compliance and Internal Audit and Risk Control Parts. [#TGT:37d016c3c16067f3] To connect these requirements in practice, the compliance officer’s responsibility for compliance reporting should be used to drive the preparation and delivery of those written reports to senior management on the required schedule. [#SRC:08b491dc52b89657] [#TGT:37d016c3c16067f3] The written reports to senior management must also indicate whether appropriate remedial measures were taken when deficiencies occurred, so the reporting overseen by the compliance officer needs to include both identification of deficiencies and an update on whether remediation has been completed. [#TGT:37d016c3c16067f3] In short, appointment by the management body establishes who owns compliance reporting, and the senior-management reporting rule sets the minimum frequency and the requirement to report on remediation status. [#SRC:08b491dc52b89657] [#TGT:37d016c3c16067f3]", "source_text": "(2) a compliance officer is appointed by the management body and that compliance officer is responsible for the compliance function and for any compliance reporting required in relation to its obligations under the regulatory system and General Organisational Requirements 4.7 ;", "target_text": "A firm must ensure that its senior management receive on a frequent basis, and at least annually, written reports on the matters covered by the Compliance and Internal Audit and Risk Control Parts . Such written reports must indicate whether the appropriate remedial measures have been taken in the event of any deficiencies.", "source_passage_id": "08b491dc52b89657", "target_passage_id": "37d016c3c16067f3", "method": "DPEL", "persona": "basic"}
{"item_id": "24312ff29834523d", "question": "If a firm has client accounts or trust accounts held for beneficiaries that might have eligible deposits, how should those accounts be labelled, and what does the PRA expect the firm to be able to send to the PRA or the FSCS (and by when) if asked?", "gold_answer": "The firm needs to label (mark) beneficiary-held accounts—specifically including client accounts and trust accounts—so that those accounts can be spotted right away as accounts that contain or may contain eligible deposits. [#TGT:68113e9f6b9da4d1] Beyond putting that marking in place, the PRA expects the firm to be able to produce account information that separates eligible accounts from ineligible accounts, so the two categories are clearly distinguished in what is provided to supervisors or the compensation scheme. [#SRC:abfeb4bf0c334fbc] The firm must be able to provide those details to the PRA or the FSCS in a format that matches the relevant rule and the PRA’s statement, rather than in an arbitrary internal format. [#SRC:abfeb4bf0c334fbc] Timing is also part of the expectation: once the PRA or the FSCS asks for the information, the firm must be able to make the separately identified eligible and/or ineligible account details available within twelve hours from the point of that request. [#SRC:abfeb4bf0c334fbc] In practice, the marking requirement and the twelve-hour delivery capability work together to support immediate identification and rapid reporting for these beneficiary-held accounts. [#TGT:68113e9f6b9da4d1] [#SRC:abfeb4bf0c334fbc]", "source_text": "The PRA expects that in compliance with the requirement in Depositor Protection 11.1 to 11.2 to mark eligible deposits/accounts ‘in a way that allows for the immediate identification of such deposits’, a firm must be able to make the details of such eligible and/or ineligible accounts (separately identified) available to the PRA or FSCS in a format consistent with the relevant rule and this statement and within twelve hours from the point of a request from the PRA or the FSCS.", "target_text": "A firm must mark accounts (including client accounts and trust accounts) which are held on behalf of beneficiaries and which contain or may contain eligible deposits in a way that allows immediate identification of such accounts.", "source_passage_id": "abfeb4bf0c334fbc", "target_passage_id": "68113e9f6b9da4d1", "method": "DPEL", "persona": "basic"}
{"item_id": "2b70c5012fc420ef", "question": "If a firm thinks it might use the Bank of England’s lending facilities (like the Discount Window Facility), what should it do when it checks whether it has enough capital, funding, and liquidity for a solvent exit, including how it values assets and runs sensitivity analysis?", "gold_answer": "If the firm anticipates using the Bank of England’s lending facilities (for example, the Discount Window Facility), it should factor that expectation into its overall view of whether it has adequate resources for a solvent exit. [#TGT:29aef3477fc07890] The firm’s check must still be a full assessment of financial resources—capital, funding, and liquidity—sized to absorb the complete costs of exiting solvently and to meet all liabilities to depositors (and other creditors as applicable). [#SRC:35122617de21cc35] That assessment needs to be grounded in realistic exit valuations of the firm’s assets and liabilities, not optimistic assumptions. [#SRC:35122617de21cc35] It also needs appropriate analysis, including sensitivity analyses of factors that could affect how much resource is required, and analysis of any balance sheet items that may be hard to transfer or sell once the main deposit and lending books have been disposed of. [#SRC:35122617de21cc35] Bringing these together, the firm should evaluate whether its capital, funding, and liquidity position—taking into account any anticipated facility usage—remains sufficient under the realistic valuations and sensitivity scenarios it has run to cover exit costs and liabilities. [#SRC:35122617de21cc35] [#TGT:29aef3477fc07890]", "source_text": "financial resources, including capital, funding, and liquidity, 55 to absorb the full costs of the solvent exit and meet all liabilities to depositors (and other creditors as applicable), with realistic exit valuations of assets and liabilities and appropriate analysis conducted (such as sensitivity analyses of factors that may impact the resources needed, and an analysis of any balance sheet items which may be difficult to transfer or sell after the main deposit and lending books have been disposed of)", "target_text": "55. This includes whether the firm anticipates the use of the Bank of England’s lending facilities (eg Discount Window Facility). See the ‘Bank of England Market Operations Guide’ for further details.", "source_passage_id": "35122617de21cc35", "target_passage_id": "29aef3477fc07890", "method": "DPEL", "persona": "basic"}
{"item_id": "4a7318fd8d9fb4ec", "question": "If a related undertaking’s items are treated as not effectively available to cover the group SCR (including when the related undertaking is a third country insurance undertaking or an insurance holding company), what does that mean for whether the related Solvency II undertaking’s own funds can be counted in the group solvency calculation?", "gold_answer": "If items of a related undertaking are assumed not to be effectively available to cover the group SCR, that assumption frames the availability assessment for group SCR coverage across several types of related undertakings, including Solvency II undertakings, third country insurance undertakings, third country reinsurance undertakings, insurance holding companies, and mixed financial holding companies. [#TGT:03e8a5e9bd172697] Where, in that setting, certain own funds eligible for the SCR of a related Solvency II undertaking cannot effectively be made available to cover the SCR of the participating Solvency II undertaking for which group solvency is calculated, those own funds must not be included in the group solvency calculation. [#SRC:cbb5ec092d926613] The only stated exception is narrow: the own funds may be included only if, and only to the extent that, they are eligible for covering the SCR of the related undertaking itself. [#SRC:cbb5ec092d926613] Operationally, you would (1) confirm the entity is a “related undertaking” within the types listed for the non-availability assumption, and (2) treat any own funds that are not effectively available for group SCR as excluded unless they still qualify for the related undertaking’s SCR coverage. [#TGT:03e8a5e9bd172697] This ensures group solvency reflects only own funds that are effectively available for group SCR purposes, with limited carry-through based on the related undertaking’s SCR eligibility. [#SRC:cbb5ec092d926613]", "source_text": "Subject to 9.4A and 9.4B , where certain own funds eligible for the SCR of a related Solvency II undertaking (other than those referred to in 9.2 and 9.3 ) cannot effectively be made available to cover the SCR of the participating Solvency II undertaking for which the solvency of a group is calculated, those own funds must not be included in the calculation of the group solvency of the group unless they are, and only in so far as they are, eligible for covering the SCR of the related undertaking .", "target_text": "The following items of a related undertaking that is a Solvency II undertaking , third country insurance undertaking or third country reinsurance undertaking , insurance holding company or mixed financial holding company shall be assumed not to be effectively available to cover the group SCR :", "source_passage_id": "cbb5ec092d926613", "target_passage_id": "03e8a5e9bd172697", "method": "DPEL", "persona": "basic"}
{"item_id": "60dc7109b80e6cf9", "question": "If you are checking what a firm or FMI needs to follow, what do you do if a guideline isn’t in Appendices 1–3, and how do you treat ESMA guideline updates that came out after the end of the transition period (even if ESMA is the source of the linked materials)?", "gold_answer": "You should not treat Appendices 1 to 3 as a complete checklist: even if a predecessor committee’s Guidelines and Recommendations are missing from those lists, firms and FMIs should still comply with them where relevant, unless they have been revoked or replaced by later Guidelines and Recommendations or by other legislation. [#SRC:fa6efa5299a687b0] Separately, when working within the scope of this SoP, you should use the ESMA Guidelines and Recommendations that were in place at the end of the transition period (the SoP provides links to those), and you should disregard changes to existing EU Guidelines and Recommendations and any new Guidelines and Recommendations issued by ESMA after the end of the transition period because they are not relevant for the purposes of this SoP. [#TGT:332c541cadcf1024] Put together, your review should (i) allow for relevant predecessor materials even if unlisted, subject to revocation/supersession, and (ii) freeze the ESMA set at the end-of-transition point for SoP relevance, even though the Bank and PRA acknowledge ESMA as the source of the linked materials. [#SRC:fa6efa5299a687b0] [#TGT:332c541cadcf1024]", "source_text": "The lists in Appendices 1 to 3 are not exhaustive. For example, Guidelines and Recommendations that were made by the predecessor committees 2 to the ESAs are not included on this list but firms and FMIs should continue, where relevant, to comply with them, unless they have been revoked or superseded by later Guidelines and Recommendations, or by other legislation.", "target_text": "Links to ESMA Guidelines and Recommendations in place as at the end of the transition period are available below. Changes to existing EU Guidelines and Recommendations, and new Guidelines and Recommendations, issued by ESMA after the end of the transition period are not relevant for the purposes of this SoP. The Bank and PRA acknowledge ESMA as the source of these materials.", "source_passage_id": "fa6efa5299a687b0", "target_passage_id": "332c541cadcf1024", "method": "DPEL", "persona": "basic"}
{"item_id": "7622f78ca6b70d15", "question": "If a firm is working out the minimum guarantee fund for long-term insurance business, what should it do when it has at least one past financial year to look at, and what amount applies if it is too new to have a preceding financial year?", "gold_answer": "The firm should start by checking whether it has a preceding financial year, because that determines whether it uses an income-based table or a fixed amount. [#SRC:7add590aa50e6993] If the firm does have one or more preceding financial years, it must look back across those years and find its highest annual contribution income for long-term insurance business, then match that highest income level to the table so it can take the minimum guarantee fund amount shown for that income band. [#SRC:7add590aa50e6993] If the firm is too new to have a preceding financial year, it cannot apply the table method that depends on identifying the highest annual contribution income in a preceding year; in that case, the minimum guarantee fund for long-term insurance business is set at £90,000. [#TGT:57922715d15fab69] This means the same firm could have different minimum guarantee fund outcomes depending on whether it has historical annual contribution income data from a preceding financial year (table-based) or lacks that history (the £90,000 default). [#SRC:7add590aa50e6993] [#TGT:57922715d15fab69]", "source_text": "Subject to 6.2 , the minimum guarantee fund for long-term insurance business is the amount in column 2 of the following table, which corresponds to the firm’s highest annual contribution income in respect of that business in any preceding financial year , as shown in column 1 of the table:", "target_text": "If a firm has not been in existence long enough to have a preceding financial year , the minimum guarantee fund for long-term insurance business is £90,000.", "source_passage_id": "7add590aa50e6993", "target_passage_id": "57922715d15fab69", "method": "DPEL", "persona": "basic"}
{"item_id": "93611ac2b616a279", "question": "When submitting the Merger Document (including the Schedule 16 Statement) and the related explanations of change, comparability and commitments, what interim financial-position disclosure must the board make because the financial information period ends before approval of the Schedule 16 Statement, and what is the stated regulatory consequence of failing to disclose such changes?", "gold_answer": "In preparing and submitting the Merger Document that includes the Schedule 16 Statement (together with the explanations of change, comparability and commitments referenced alongside it), the board must address the fact that the financial information necessarily covers a period ending before the Schedule 16 Statement is approved. [#SRC:f1c8b930cd8f5ee1] Specifically, the board is required to state whether there have been any material changes to the financial position in the interim between the end of that financial-information period and the approval date. [#TGT:ee19b3e79f8edaa1] If a material change has occurred and its effect cannot be quantified, the board must still describe the change so that members understand it has been identified and is relevant to their consideration of the proposed merger. [#TGT:ee19b3e79f8edaa1] This interim-change disclosure is therefore a necessary complement to the Merger Document package (including the Schedule 16 Statement and the associated explanations) being put forward. [#SRC:f1c8b930cd8f5ee1] A failure to disclose such interim material changes is not treated as immaterial: it will be relevant to the PRA’s later consideration of the society’s application for confirmation of the merger. [#TGT:ee19b3e79f8edaa1]", "source_text": "(c) the Merger Document, including the Schedule 16 Statement, unless consent to proceed by way of board resolution is being sought in respect of the transferee society, together with the explanations of change, comparability and commitments referred to in paragraph 3.73 to 3.75 and 3.95 ;", "target_text": "Since the financial information will necessarily relate to a period ending somewhat before the date of approval of the Schedule 16 Statement, the board is required to state whether or not there have been any material changes to the financial position in the interim. If the effect of a change cannot be quantified, it must be described so that the members at least know that it has been identified and is relevant to their consideration of the proposed merger. Failure to disclose such changes will be relevant to the PRA’s subsequent consideration of the society’s application for confirmation of the merger (see paragraphs 3.157 , 3.169 and 3.170 ).", "source_passage_id": "f1c8b930cd8f5ee1", "target_passage_id": "ee19b3e79f8edaa1", "method": "DPEL", "persona": "professional"}
{"item_id": "e84e27c0eecb6f43", "question": "Where the PRA has deferred (in whole or in part) a class A2 member’s obligation to pay its share of a recapitalisation payment levy because payment would jeopardise the liquidity or solvency of the firm, when must the deferred amount be paid, and what is the maximum duration of any single deferral (including whether it can be renewed)?", "gold_answer": "A deferred contribution must be paid once making the payment no longer threatens the firm’s liquidity and solvency, and any PRA-granted deferral of a class A2 member’s share of a recapitalisation payment levy cannot run for more than six months at a time, though it may be renewed if the firm asks. [#SRC:f026573295165d20] [#TGT:9b64fbbd8245427b] The trigger for payment is the point at which paying the deferred amount ceases to jeopardise the liquidity and solvency of the firm, meaning the deferral is not a permanent waiver but a timing adjustment tied to the firm’s financial condition. [#SRC:f026573295165d20] The PRA’s ability to defer applies where it considers that the contributions would jeopardise the liquidity or solvency of the firm, and it may defer the obligation in whole or in part for a class A2 member in relation to a recapitalisation payment levy. [#TGT:9b64fbbd8245427b] Even if the liquidity/solvency concern persists, the PRA cannot grant a single deferral for longer than six months; however, the firm can request renewal, allowing the deferral to be extended through successive periods if renewed. [#TGT:9b64fbbd8245427b] Accordingly, compliance planning should align both the condition-based payment point and the six-month cap with potential renewal requests. [#SRC:f026573295165d20] [#TGT:9b64fbbd8245427b]", "source_text": "Any contributions deferred pursuant to 46.2 or 46.2A shall be paid when the payment no longer jeopardises the liquidity and solvency of the firm .", "target_text": "The PRA may defer, in whole or in part, a class A2 member’s obligation to pay a share of a recapitalisation payment levy if the PRA considers that such contributions would jeopardise the liquidity or solvency of the firm . Such deferral shall not be granted for a longer period than six months but may be renewed upon request of the firm .", "source_passage_id": "f026573295165d20", "target_passage_id": "9b64fbbd8245427b", "method": "DPEL", "persona": "professional"}
{"item_id": "35c993865be72535", "question": "When constructing a matching adjustment (MA) portfolio that includes in-payment income protection claims, how should a firm reconcile the PRA’s view that in-payment elements may be eligible where separately identifiable and managed separately with the rule that insurance or reinsurance obligations must not be split into different parts except for an eligible element, and what underwriting risk exposure limits apply to recovery time risk in that context?", "gold_answer": "A firm may only treat part of an income protection contract separately for MA portfolio composition where that part qualifies as an eligible element, and the PRA’s discussion of “in-payment elements” is framed as potentially eligible only when they are separately identifiable and can be organised and managed separately (including in line with regulation 4(6) of the IRPR regulations). [#SRC:aa234508c5cb946b] The general rule for this Part is that insurance or reinsurance obligations under a contract must not be split into different parts when composing the relevant portfolio, except in the case of an eligible element, so any separation of an in-payment element must fit within that exception rather than being a general permission to split obligations. [#TGT:80ba42a4e7626379] In that setting, the permitted underwriting risks connected to the portfolio of liabilities may include recovery time risk, described as the risk that policyholders receiving income protection payments take longer than expected to recover from sickness. [#SRC:aa234508c5cb946b] Unlike mortality risk, the PRA indicates there is no restriction on the exposure to recovery time risk in firms’ MA portfolios, but it also states it does not expect recognising recovery time risk to justify bringing in liabilities other than income protection claims in payment. [#SRC:aa234508c5cb946b]", "source_text": "Matching Adjustment 2.2(2) specifies that the permitted underwriting risks connected to the portfolio of liabilities may include recovery time risk, where this is the risk that policyholders in receipt of income protection payments take longer to recover from sickness than expected. Matching Adjustment 2.3 and 2.5 provide that in-payment elements of income protection contracts may be eligible for inclusion, where they are separately identifiable and can be organised and managed separately in accordance with regulation 4(6) of the IRPR regulations. The PRA considers that this will allow in-payment claims under both group and individual income protection policies to be permitted within MA portfolios, where the claims are not subject to future premiums. Unlike with mortality risk, there is no restriction on the exposure to recovery time risk in firms’ MA portfolios. The PRA does not expect that the inclusion of recovery time as an underwriting risk should lead to types of liabilities other than income protection claims in payment being included in MA portfolios.", "target_text": "For the purposes of this Part, the insurance or reinsurance obligations of an insurance or reinsurance contract must not be split into different parts when composing the relevant portfolio of insurance or reinsurance obligations , other than in the case of an eligible element .", "source_passage_id": "aa234508c5cb946b", "target_passage_id": "80ba42a4e7626379", "method": "DPEL", "persona": "professional"}
{"item_id": "4bfde5f7fb141b41", "question": "If a firm is new and hasn’t finished a full financial year yet, what valuation should it use to pay periodic fees in its first fee year, and what should it use in its second fee year if it got its new or extended permission between 1 January (in its first fee year) and 1 April (in its second fee year)?", "gold_answer": "The firm should use projected valuation in both situations described, but the trigger conditions differ between the first and second fee years. [#TGT:bc923fb7c74a4666] [#SRC:d75ff793a1100dc6] In the first fee year, the periodic fees are paid based on the firm’s projected valuation for the first twelve months of its new business. [#TGT:bc923fb7c74a4666] For the second fee year, the projected-valuation approach applies only where the firm has not completed a full financial year by the start of the fee year and it is in its second fee year, and it received its new or extended permission relevant to the activity during the period from 1 January in its first fee year to 1 April in its second fee year. [#SRC:d75ff793a1100dc6] When those second-fee-year conditions are met, the firm should apply projected valuations in the way referenced (as set out in 3.7). [#SRC:d75ff793a1100dc6] Linking the two passages, the first-fee-year rule establishes projected valuation as the basis for periodic fees for the first twelve months of new business, and the second-fee-year rule extends the use of projected valuations into the second fee year for firms that are still without a completed full financial year and that obtained the relevant permission within the stated date window. [#TGT:bc923fb7c74a4666] [#SRC:d75ff793a1100dc6]", "source_text": "(1) a firm which has not completed a full financial year by the start of the fee year should, if it is in its second fee year and received its new or extended permission relevant to the activity between 1 January in its first fee year and 1 April in its second fee year , apply projected valuations as set out in 3.7 ;", "target_text": "A firm in its first fee year pays periodic fees based on its projected valuation for the first twelve months of its new business as follows:", "source_passage_id": "d75ff793a1100dc6", "target_passage_id": "bc923fb7c74a4666", "method": "DPEL", "persona": "basic"}
{"item_id": "ce08c505da76f1ed", "question": "In a merger where a bonus is proposed to equalise reserves between a transferor society and a transferee society (and potentially also to pay a bonus to members of the transferee society), how should the societies determine which Merger Resolutions must include member approval of the bonus payments, taking into account the prudence condition and the prescribed-limit test based on total gross cost?", "gold_answer": "Member approval for any proposed bonus payment(s) must be obtained through the Merger Resolutions, and the resolution(s) that must carry that approval depend on which society’s funds are being distributed and whether the total gross cost is within the prescribed limit. [#TGT:9dfe512afd4bf0e8] Where a bonus is used to address differing capital ratios—such as paying members of a transferor society that has a higher capital ratio than the transferee society to help equalise the reserves brought into the combined society—the proposal still needs to be structured so that any equalisation (including any decision to also pay a bonus to members of the transferee society) is only taken forward if it is prudent to equalise reserves at a level below the transferee society’s capital ratio. [#SRC:b67dac575cd27cc6] Operationally, the Merger Resolutions should be drafted as follows: - Calculate the total gross cost of the proposed bonus(es) without adjusting for prospective corporation tax recovery, and compare it to the prescribed limit. [#TGT:9dfe512afd4bf0e8] - If the total gross cost is within the prescribed limit, include the bonus-approval wording only in each Merger Resolution of the society whose funds are to be distributed (i.e., the paying society). [#TGT:9dfe512afd4bf0e8] - If the total gross cost exceeds the prescribed limit, include the bonus-approval wording in each Merger Resolution of each participating society. [#TGT:9dfe512afd4bf0e8] - Ensure the rationale for any reserve equalisation (including paying both sets of members) aligns with the prudence constraint described for setting the combined society’s reserve level. [#SRC:b67dac575cd27cc6]", "source_text": "A bonus may, for example, be paid to the members of a transferor society with a higher capital ratio than the transferee society so as to equalise the reserves which both bring to the combined society. If it is thought desirable also to pay a bonus to the members of the transferee society, then the reserves of the combined society may be equalised at a level below the capital ratio of the transferee society, but only if it is prudent to do so. The statutory requirements for approval of bonus payments are described in paragraph 3.107 .", "target_text": "The members approval of bonus payments is required as part of the Merger Resolutions (see section 96(4) to (6) of the 1986 Act) and see paragraph 3.59 for the PRA’s view of what may constitute a bonus). If the total gross cost of the proposed bonus(es) (ie without any adjustment for prospective corporation tax recovery) is within the prescribed limit, then approval for it need only be included in each of the Merger Resolutions of the society whose funds are to be distributed. If it exceeds that limit then it must be included in each of the Merger Resolutions of each participating society. The prescribed limit was changed by the Building Societies (Mergers) (Amendment) Regulations SI 1995/1874 amending S1 1987/2005 and now is:", "source_passage_id": "b67dac575cd27cc6", "target_passage_id": "9dfe512afd4bf0e8", "method": "DPEL", "persona": "professional"}
{"item_id": "ef7242ce87045928", "question": "If a large institution’s non-performing loans and advances ratio is 5% or more, what extra templates does it have to publish each year, and when does it have to start publishing them based on the rule about two back-to-back quarters in the last four quarters before the disclosure reference date?", "gold_answer": "When a large institution has a non-performing loans and advances ratio that is at least 5%, it must make the additional disclosures (linked to points (c) and (f) of Article 442 of the CRR) using templates UK CR2a, UK CQ2, CQ6, UK CQ8, and columns b and d of Templates UK CQ4 and UK CQ5, following the Annex XV templates and Annex XVI instructions, and it must do so annually. [#TGT:f4069472e0482e37] The institution must begin making disclosure in line with the 5% threshold rule once it has reached or exceeded 5% in two consecutive quarters during the four quarters before the disclosure reference date. [#SRC:d188f8c0946e8de1] For the first time it discloses, the institution must include the templates that are subject to the 5% threshold if it meets the threshold on that first disclosure reference date. [#SRC:d188f8c0946e8de1] Putting these together, the annual obligation to use the specified UK templates applies when the ratio is at or above 5%, and the start point is determined by checking whether the institution hit or exceeded 5% in two back-to-back quarters in the prior four-quarter window, while also ensuring the first disclosure reference date includes the threshold-subject templates if the ratio is at or above 5% on that date. [#TGT:f4069472e0482e37] [#SRC:d188f8c0946e8de1]", "source_text": "Institutions shall commence disclosure in accordance with paragraph 3 where they have reached or exceeded the 5% threshold in two consecutive quarters during the four quarters prior to the reference date of the disclosure. For the reference date of the first disclosure, institutions shall disclose the templates subject to the 5% threshold if they comply with the threshold on that disclosure reference date.", "target_text": "In addition to the templates referred to in paragraph 22 and in order to convey sufficiently comprehensive and comparable information for users of that information to assess the risk profiles of institutions, large institutions with a ratio of gross carrying amount of non-performing loans and advances divided by the total gross carrying amount of loans and advances subject to the definition of non-performing according to Article 47a of the CRR equal to or higher than 5% shall make the disclosure required in points (c) and (f) of Article 442 of the CRR also in accordance with templates UK CR2a , UK CQ2 , CQ6 and UK CQ8 , columns b and d of Templates UK CQ4 and UK CQ5 set out in Annex XV and with the instructions set out in Annex XVI , on an annual basis.", "source_passage_id": "d188f8c0946e8de1", "target_passage_id": "f4069472e0482e37", "method": "DPEL", "persona": "basic"}
{"item_id": "ea5f6eddb7d8f896", "question": "When a society establishes or reviews its corporate governance arrangements, how should it decide whether to have regard to the UK Corporate Governance Code or the Combined Code, and what specific scope limitation applies to the Combined Code referenced in the materials?", "gold_answer": "A society that is not publicly quoted is expected, when setting up and when reassessing its corporate governance arrangements, to take into account an appropriate governance code, choosing between the UK Corporate Governance Code and the Combined Code depending on which is suitable in the circumstances. [#SRC:1da93b3de3471f0b] Where the society looks to the Combined Code, the relevant Combined Code is the version on Corporate Governance that was developed by the Corporate Governance Committee of the Financial Reporting Council and is expressly tied to accounting periods that begin before 29 June 2010. [#TGT:a3566db56919a9f0] In practical terms, this means the society’s “have regard to” exercise for the Combined Code is anchored to that identified Combined Code and its stated accounting-period applicability, rather than an unspecified or open-ended version. [#TGT:a3566db56919a9f0] The trigger for considering these codes is the society’s act of establishing and reviewing its corporate governance arrangements, and the society’s non-publicly-quoted status does not remove the expectation to consider the codes; it frames the context in which the society should select the appropriate one. [#SRC:1da93b3de3471f0b]", "source_text": "Although societies are not publicly quoted, they should have regard to the UK Corporate Governance Code 4 or the Combined Code 5 as appropriate when they establish and review their corporate governance arrangements.", "target_text": "5. The Combined Code on Corporate Governance, developed by the Corporate Governance Committee of the Financial Reporting Council for accounting periods beginning before 29 June 2010.", "source_passage_id": "1da93b3de3471f0b", "target_passage_id": "a3566db56919a9f0", "method": "DPEL", "persona": "professional"}
{"item_id": "93ba6b888a569a05", "question": "Where a firm excludes exposures under the resolution exemption in the Large Exposures Part of the PRA Rulebook, and those exposures are not included in MREL reporting as specified in Supervisory Statement (SS) 19/13 ‘Resolution planning’, what notification is required and which June 2018 Bank of England webpage is identified for SS 19/13?", "gold_answer": "A firm that has excluded exposures using the resolution exemption in the Large Exposures Part of the PRA Rulebook must notify the PRA when those excluded exposures are not included in MREL reporting in the manner specified in Supervisory Statement (SS) 19/13 ‘Resolution planning’. [#SRC:5ef0f6dbfa3bd3bb] This notification trigger is tied specifically to the combination of (i) use of the resolution exemption for Large Exposures and (ii) the fact that the exposures are not captured in MREL reporting as SS 19/13 sets out, so the firm should treat the absence from MREL reporting (as specified in SS 19/13) as the condition that makes the PRA notification necessary. [#SRC:5ef0f6dbfa3bd3bb] The referenced SS 19/13 ‘Resolution planning’ is identified with a June 2018 link on the Bank of England website at www.bankofengland.co.uk/prudential-regulation/publication/2013/resolution-planning-ss. [#TGT:695e320d362f1655] Accordingly, the firm’s compliance action is to notify the PRA in the stated circumstances, and the SS 19/13 reference point for the MREL reporting specification is the June 2018 Bank of England webpage provided. [#SRC:5ef0f6dbfa3bd3bb] [#TGT:695e320d362f1655]", "source_text": "Firms that exclude exposures pursuant to the resolution exemption in the Large Exposures Part of the PRA Rulebook should notify the PRA if those exposures are not included in MREL reporting as specified in Supervisory Statement (SS) 19/13 ‘Resolution planning’ . 5", "target_text": "5. June 2018: www.bankofengland.co.uk/prudential-regulation/publication/2013/resolution-planning-ss .", "source_passage_id": "5ef0f6dbfa3bd3bb", "target_passage_id": "695e320d362f1655", "method": "DPEL", "persona": "professional"}
{"item_id": "26c0c0b859e35872", "question": "How should a firm align its risk-management system’s scope of covered risks with the calibration expectation that all quantifiable risks are taken into account, and which minimum risk categories must be reflected across both the SCR-related coverage and the system’s specified areas?", "gold_answer": "A firm should design its risk-management system so that it both (i) covers the risks relevant to the SCR calculation (and those not, or not fully, captured by that calculation) and (ii) is aligned with the expectation that all quantifiable risks to which the firm is exposed are taken into account through calibration. [#SRC:ec68cf68d094e876] [#TGT:f261181a95a3ca51] The system must be effective and embedded in the firm’s organisational structure and decision-making, with proper consideration of persons who have key functions, so that the calibration and risk coverage are operationally implemented rather than treated as a standalone exercise. [#SRC:ec68cf68d094e876] In practical terms, the firm should ensure that the risk coverage includes the risks to be included in the SCR calculation and also addresses risks that are not, or not fully, included in that calculation, while still ensuring that all quantifiable risks are taken into account. [#SRC:ec68cf68d094e876] [#TGT:f261181a95a3ca51] At a minimum, the calibration expectation explicitly includes non-life underwriting risk, life underwriting risk, health underwriting risk, market risk, credit risk, and operational risk, and the risk-management system must cover specified areas including underwriting and reserving, asset-liability management, investment risk management (notably derivatives, quasi-derivatives and similar commitments), liquidity and concentration risk management, operational risk management, and reinsurance and other risk-mitigation techniques. [#TGT:f261181a95a3ca51] [#SRC:ec68cf68d094e876]", "source_text": "(2) That risk-management system must: (a) be effective and well integrated into the organisational structure and decision-making processes of the firm with proper consideration of the persons who have key functions ; (b) cover the risks to be included in the calculation of the SCR as set out in Solvency Capital Requirement - General Provisions 3.3(1) , as well as the risks which are not, or not fully, included in the calculation thereof; and (c) cover at least the following areas: (i) underwriting and reserving as set out in 3.1A(1) ; (ii) asset-liability management as set out in 3.1A(2) ; (iii) investment risk management, in particular derivatives , quasi-derivatives and similar commitments, as set out in 3.1A(3) ; (iv) liquidity risk and concentration risk management: as set out in 3.1A(4) and 3.1A(5) ; (v) operational risk management as set out in 3.1A(6) ; and (vi) reinsurance and other risk-mitigation techniques as set out in 3.1A(7) .", "target_text": "(1) must be calibrated to ensure that all quantifiable risks to which the firm is exposed are taken into account, including at least the non-life underwriting risk , life underwriting risk , health underwriting risk , market risk , credit risk , and operational risk ;", "source_passage_id": "ec68cf68d094e876", "target_passage_id": "f261181a95a3ca51", "method": "DPEL", "persona": "professional"}
{"item_id": "a017532316d50fb0", "question": "For a firm that has permission to use a partial or full internal model, what quarterly submission to the PRA is required for model changes, and what specific template and instruction source must be used to provide both change details and qualitative support?", "gold_answer": "A firm with permission to use a partial or full internal model must provide the PRA with a quarterly submission covering model changes, and it must do so using the specified PRA template and instructions. [#SRC:6b80f0d656b136bd] The quarterly content must be a summary of both minor and major model changes provided to the PRA, reflecting the requirement tied to Article 6(3) of Chapter 2A of the Reporting Part of the PRA Rulebook and the EIOPA Guidelines on the use of internal models. [#SRC:6b80f0d656b136bd] To meet the quarterly reporting format and information expectations, firms using an internal model must submit quarterly template QMC.01 of Chapter 9, which requires information on model changes together with supporting qualitative information. [#TGT:96395cb1453e2aa2] The submission must be prepared in line with the instructions set out in section QMC.01 of Chapter 10, which governs how the template is to be completed and what supporting qualitative detail is to accompany the model-change information. [#TGT:96395cb1453e2aa2] Taken together, this means the firm’s quarterly summary of minor and major changes is operationalized through template QMC.01 and its Chapter 10 instructions, and the deliverable is submitted to the PRA each quarter. [#SRC:6b80f0d656b136bd] [#TGT:96395cb1453e2aa2]", "source_text": "In accordance with Article 6(3) of Chapter 2A of the Reporting Part of the PRA Rulebook and the EIOPA Guidelines on the use of internal models, firms with permission to use a partial or full internal model are required to provide a quarterly summary of minor and major model changes to the PRA.", "target_text": "Firms using an internal model must submit to the PRA quarterly template QMC.01 of Chapter 9 , specifying information on model changes and supporting qualitative information, in accordance with the instructions set out in section QMC.01 of Chapter 10 .", "source_passage_id": "6b80f0d656b136bd", "target_passage_id": "96395cb1453e2aa2", "method": "DPEL", "persona": "professional"}
{"item_id": "6d30b59252a7135a", "question": "For a TWD firm, how should the firm align its capability to refresh the material components of the TWD option that require judgement with the requirement to run sensitivity analyses of key market factors, including the expected timeframe for doing so and the minimum scope of sensitivities?", "gold_answer": "A TWD firm should be able to use its data refresh and full plan refresh capabilities to update the material, judgement-driven components of its TWD option within a timeframe ranging from a matter of days to a matter of weeks, with the exact speed depending on the nature and extent of the stress. [#SRC:58ebd6a4c26d1aaa] In doing so, the firm’s refresh process should incorporate sensitivity analyses focused on the key market factors in the TWD scenario, as well as the assumptions and judgments that could materially affect capital and liquidity projections and RBLs. [#TGT:5fd58dcf50062ad4] Practically, this means the refresh capability is not only about updating inputs, but also about testing how changes in those key factors and related assumptions/judgments would move the firm’s projected capital and liquidity outcomes and its RBLs. [#TGT:5fd58dcf50062ad4] The sensitivity work should be included as part of the refresh of the material components that require judgement, and it should cover updates to the factors referenced for sensitivity analysis in the relevant paragraphs identified in the expectation. [#SRC:58ebd6a4c26d1aaa] The minimum expectation is that sensitivities of capital and liquidity to the specified factors are included, rather than being optional or ad hoc. [#TGT:5fd58dcf50062ad4]", "source_text": "The PRA expects that TWD firms’ data refresh and full plan refresh capabilities can be utilised such that TWD firms are able to perform a refresh of the material components of the TWD option that require judgement, between a matter of days and a matter of weeks (depending on the nature and extent of the stress). 29 This should include sensitivity analyses of updates to the factors set out in paragraphs 4.49 - 4.51 .", "target_text": "TWD firms should have the ability to perform sensitivity analyses of the key market factors set out in the TWD scenario, assumptions, and judgments that could have a material impact on capital and liquidity projections and on RBLs. At a minimum, sensitivities of capital and liquidity to the following factors should be included:", "source_passage_id": "58ebd6a4c26d1aaa", "target_passage_id": "5fd58dcf50062ad4", "method": "DPEL", "persona": "professional"}
{"item_id": "396a13753cac2073", "question": "When giving notice of an application under the Business Transfers Regulations, how should the firm(s) structure the accompanying statement and summary so recipients can understand the scheme’s effect, and what must be made available on request (including whether the internet may be used), given that the notice must go to specified categories of policyholders and certain reinsurers and should explain how and when representations are to be made to the court?", "gold_answer": "The firm(s) should treat the application notice as a package that both reaches the required recipients and equips them to understand the scheme and participate effectively in the court process. The notice must be sent to all policyholders of the parties and to reinsurers (or a person acting on its behalf) whose reinsurance contracts are proposed to be transferred, unless the court directs otherwise. [#TGT:c99af11004d99259] Alongside that notice, it would normally be appropriate to include a statement setting out the scheme’s terms and summarising the scheme report, drafted so that each recipient can grasp in broad terms how the scheme is likely to affect them; this is best achieved by a clear, concise summary that still contains enough detail, avoiding an overly long or hard-to-understand summary. [#SRC:763120bb6b209201] The notice and related communications should also explain how and when affected parties’ representations should be made so the court can consider them. [#TGT:c99af11004d99259] In addition, the Business Transfers Regulations require the scheme report, the notice, and the statement to be made available to anyone who requests them, and the internet may be used to provide access where it is suitable for the person making the request. [#SRC:763120bb6b209201]", "source_text": "It would normally be appropriate to include with the notice referred to in 2.49 above a statement setting out the terms of the scheme and containing a summary of the scheme report. Ideally every recipient should understand in broad terms from the summary how the scheme is likely to affect them. This objective will be most nearly achieved if the summary is clear and concise while containing sufficient detail for the purpose. A lengthy summary or one that was hard to understand would not be appropriate. The Business Transfers Regulations require the scheme report, the notice and the statement to be made available to anyone requesting them. The internet can be used for this purpose if it is suitable for the person making the request.", "target_text": "Under the Business Transfers Regulations, unless the court directs otherwise, notice of the application must be sent to all policyholders of the parties and reinsurers (or a person acting on its behalf) any of whose contracts of reinsurance are proposed to be transferred as part of the insurance business transfer scheme. It may also be appropriate to give notice to others affected, for example, to anyone with an interest in the policies being transferred who has notified the transferor of their interest. This notice, along with other communications and advertising by or and on behalf of the firm(s), should provide details of how and when any representations by affected parties should be made in order to be considered by the court.", "source_passage_id": "763120bb6b209201", "target_passage_id": "c99af11004d99259", "method": "DPEL", "persona": "professional"}
{"item_id": "eabaf45e0d68dc5c", "question": "If you are writing a PRA policy statement about varying approvals, which FSMA section do you cite for the requirement that the PRA and FCA publish their policy statements, and which FSMA sections do you cite for the power to vary approvals?", "gold_answer": "You should cite one FSMA section for the obligation to publish the policy statement, and different FSMA sections for the legal power that the policy statement is discussing. [#SRC:ad7dc485c7e56a6e] For the publication requirement, the PRA’s statement of policy is described as being issued in accordance with section 63ZD of the Financial Services and Markets Act 2000 (FSMA), and that section is described as requiring the PRA and the Financial Conduct Authority (FCA) to issue statements of their respective policies. [#SRC:ad7dc485c7e56a6e] For the underlying power on the specific topic of varying approvals, you should cite sections 63ZA or 63ZB of FSMA, because those are identified as the sections where the PRA’s and FCA’s power to vary approvals is set out. [#TGT:294fe7b55286ce9a] Using both references together makes the explanation complete: section 63ZD supports why the PRA and FCA are issuing policy statements at all, while sections 63ZA/63ZB identify where the power being covered (varying approvals) sits in FSMA. [#SRC:ad7dc485c7e56a6e] [#TGT:294fe7b55286ce9a]", "source_text": "This statement of policy is issued by the Prudential Regulation Authority (PRA) in accordance with section 63ZD of the Financial Services and Markets Act 2000 (FSMA) as amended by the Financial Services (Banking Reform)Act 2013, 1 and the Bank of England and Financial Services Act 2016, which requires the PRA and the Financial Conduct Authority (FCA) to issue a statement of their respective policies on:", "target_text": "2. The PRA’s and FCA’s power to vary approvals are set out in Sections in sections 63ZA or 63ZB of FSMA.", "source_passage_id": "ad7dc485c7e56a6e", "target_passage_id": "294fe7b55286ce9a", "method": "DPEL", "persona": "basic"}
{"item_id": "d05539f1b6b2b7e0", "question": "If markets are stressed, do firms change the MA calculation method for TPs, and when can they add more to the fundamental spread than the amount worked out under 4.10–4.16 (including the kinds of add-ons mentioned in 4.16 and 4.17)?", "gold_answer": "When calculating TPs, the MA and FS are determined using the approach set out in Chapter 4 of the Matching Adjustment Part of the PRA rulebook, and the PRA view is that the MA calculation method should stay the same even in stress conditions. [#SRC:dd04e755dbd1506a] Even so, firms should actively consider whether the assumptions feeding into the MA and FS used for the TP calculation are still suitable under stress, including any extra amounts added to the FS (for example, additions connected to assets with HP cash flows under Matching Adjustment 4.16, or additions made for other reasons under Matching Adjustment 4.17). [#SRC:dd04e755dbd1506a] Separately, a firm is allowed to increase the fundamental spread above the level calculated under 4.10 to 4.16 if that increase is needed to make sure the fundamental spread covers all risks the firm keeps. [#TGT:26262b6ce882a0b1] Putting these points together: the method stays stable, but the firm should revisit assumptions and can raise the fundamental spread where necessary so retained risks are fully covered. [#SRC:dd04e755dbd1506a] [#TGT:26262b6ce882a0b1]", "source_text": "Chapter 4 of the Matching Adjustment Part of the PRA rulebook (restating as rules the relevant provisions of the IRPR regulations) sets out how the MA and FS should be calculated for the purpose of determining TPs. While the PRA considers that the MA calculation method should not change in stress conditions, firms should consider if the assumptions used to calculate the MA and FS for the TP calculation, including any additions to the FS (either for assets with HP cash flows as per Matching Adjustment 4.16 or for other reasons as per Matching Adjustment 4.17 ), remain appropriate in stress conditions.", "target_text": "A firm may increase the fundamental spread calculated under 4.10 to 4.16 where necessary to ensure it covers all risks retained by the firm .", "source_passage_id": "dd04e755dbd1506a", "target_passage_id": "26262b6ce882a0b1", "method": "DPEL", "persona": "basic"}
{"item_id": "b0ee9c5669ad89f3", "question": "For a subsidiary assessing its Senior Management Functions (SMFs) and maintaining governance documentation, how should it treat its Statements of Responsibilities (SoR) in light of the fact that Statements of Responsibilities are those required by section 60(2A) of FSMA, and what related documentation and allocation expectations apply?", "gold_answer": "A subsidiary should treat its Statements of Responsibilities (SoR) as the Statements of Responsibilities required by section 60(2A) of FSMA, and it should keep those SoR current as part of its broader senior management governance arrangements. [#TGT:9de8b5441f652d6e] In practice, the subsidiary is expected to ensure it has an appropriate number of SMFs that reflects its size, complexity, and governance structure, and to do so consistently with the principles in SS28/15 on strengthening individual accountability in banking. [#SRC:f199857a7c43ed1d] Alongside calibrating SMFs, the subsidiary should ensure that both its Management Responsibilities Maps and its SoR are up to date. [#SRC:f199857a7c43ed1d] It should also allocate responsibilities in accordance with the Allocation of Responsibilities Part of the PRA Rulebook and SS28/15, using the up-to-date SoR and Management Responsibilities Maps as the key governance artefacts supporting that allocation. [#SRC:f199857a7c43ed1d] Because the SoR are specifically the FSMA section 60(2A) Statements of Responsibilities, the subsidiary’s obligation to keep SoR current should be understood as maintaining those section 60(2A) documents in an up-to-date state within its accountability framework. [#TGT:9de8b5441f652d6e]", "source_text": "A subsidiary should ensure that they have an appropriate number of SMFs according to its size, complexity, and governance structure, in line with the principles outlined in SS28/15 ‘Strengthening individual accountability in banking’ . 34 Firms should particularly ensure that Management Responsibilities Maps and Statements of Responsibilities (SoR) are up to date and that responsibilities are allocated in accordance with the Allocation of Responsibilities Part of the PRA Rulebook and SS28/15 . 35", "target_text": "35. Statements of Responsibilities are those required by section 60 (2A) of FSMA: https://www.legislation.gov.uk/ukpga/2000/8/section/60 .", "source_passage_id": "f199857a7c43ed1d", "target_passage_id": "9de8b5441f652d6e", "method": "DPEL", "persona": "professional"}
{"item_id": "6eed2ff71ffe5af7", "question": "If a firm is in a group covered by 2.1(3), does it still have to follow Operational Resilience – Solvency II Firms 2.1 and 2.2 for its important group business services when 22.2, 22.3 and 22.4 do not apply because the parent undertaking is based in an overseas jurisdiction designated under regulation 11 (linked to regulation 14 of the IRPR regulations) and regulation 14(3) applies?", "gold_answer": "Yes—the text sets up two different effects that you must apply together: one creates an operational resilience compliance duty for important group business services, and the other removes the application of certain numbered provisions in a specific overseas-supervision situation. [#TGT:3ae851f798bf5091] When the firm is a member of a group covered by 2.1(3) (noting the “subject to 22.5” wording), the firm must also comply with Operational Resilience – Solvency II Firms 2.1 and 2.2 in relation to its important group business services. [#TGT:3ae851f798bf5091] Separately, for a firm that is a member of a group covered by 2.1(3), 22.2, 22.3 and 22.4 do not apply if the group’s parent undertaking has its head office in a third country that is an overseas jurisdiction designated under regulation 11 in relation to regulation 14 of the IRPR regulations for insurance group supervision, and regulation 14(3) applies. [#SRC:b6b6500b2b9939c8] Putting these together, you should not treat the non-application of 22.2–22.4 as cancelling the stated requirement to comply with Operational Resilience – Solvency II Firms 2.1 and 2.2 for important group business services; instead, you apply the operational resilience duty based on the group coverage, while separately recognizing that 22.2–22.4 are switched off only when the overseas-jurisdiction and regulation 14(3) conditions are met. [#SRC:b6b6500b2b9939c8] [#TGT:3ae851f798bf5091]", "source_text": "Where a firm is a member of a group covered by 2.1(3) , 22.2 , 22.3 and 22.4 do not apply if, the third country in which the group's parent undertaking has its head office is an overseas jurisdiction designated under regulation 11 in relation to regulation 14 of the IRPR regulations in respect of insurance group supervision and paragraph (3) of regulation 14 of the IRPR regulations applies.", "target_text": "Where a firm is a member of a group covered by 2.1(1) , 2.1(2) or, subject to 22.5 , 2.1(3) , the firm must also comply with Operational Resilience – Solvency II Firms 2.1 and 2.2 in relation to its important group business services .", "source_passage_id": "b6b6500b2b9939c8", "target_passage_id": "3ae851f798bf5091", "method": "DPEL", "persona": "basic"}
{"item_id": "3ca89bd91e0f6515", "question": "If a firm is dealing with capital instruments that count toward regulatory capital resources or own funds, when does it have to tell the PRA for CET1/AT1 compared with Tier 2, and how does that fit with the Rulebook’s idea of “pre-issuance notification” and “post-notification” in Rules 7A to 7D?", "gold_answer": "The timing depends on the type of capital instrument, and the difference lines up with the Rulebook’s split between pre-issuance notification and post-notification. [#TGT:b9bc12dacc3dd268] For CET1 and AT1 capital instruments that will count toward regulatory capital resources or own funds (at solo, sub-consolidated, group consolidated level, or any combination), the firm is generally required to notify the PRA at least one month before the planned issuance date or before the planned amendment/variation to the terms. [#SRC:1fbc1202165b9d05] This matches the statement that Rules 7A to 7D require pre-issuance notification for CET1 and AT1 issuances. [#TGT:b9bc12dacc3dd268] For Tier 2 capital instruments that will count toward regulatory capital resources or own funds at those same levels, the firm is generally required to notify the PRA immediately after the instrument is issued or immediately after the terms are amended/varied. [#SRC:1fbc1202165b9d05] That “after the fact” timing aligns with the Rulebook’s description of post-notification for Tier 2 issuances under Rules 7A to 7D. [#TGT:b9bc12dacc3dd268] So, the practical takeaway is: CET1/AT1 notice is sent in advance, while Tier 2 notice is sent right after the event. [#SRC:1fbc1202165b9d05]", "source_text": "Firms are generally required 6 to notify the PRA at least one month before the intended date of issuance or amendment or variation to the terms of each CET1 or AT1 capital instrument, and immediately after issuing or amending or varying the terms of each Tier 2 capital instrument, that will count towards regulatory capital resources or own funds, either at solo, sub-consolidated or group consolidated level or any combination of these.", "target_text": "6. Rules 7A to 7D of Definition of Capital Part of the PRA Rulebook require pre-issuance notification for CET1 and AT1 issuances, and post-notification for Tier 2 issuances.", "source_passage_id": "1fbc1202165b9d05", "target_passage_id": "b9bc12dacc3dd268", "method": "DPEL", "persona": "basic"}
{"item_id": "d099e7ce51d8cbaa", "question": "When a credit union reschedules a delinquent loan or capitalises arrears, what is the expected governance action by directors regarding the provisioning amount, and for how long must the relevant provision be kept in place in order to demonstrate accurate compliance with the provisioning requirements in Rules 3.11 and 3.12 of the Credit Unions Part of the PRA Rulebook?", "gold_answer": "Directors are expected to take active, ongoing steps to assure themselves that their credit union is accurately complying with the provisioning requirements in Rules 3.11 and 3.12 of the Credit Unions Part of the PRA Rulebook, including in situations where loan terms are changed. [#SRC:837cf352ecff942f] In the specific case where a delinquent loan is rescheduled or the arrears are capitalised, accurate compliance requires that the provision level that applied immediately before the rescheduling or recapitalisation is not reduced simply because of that restructuring event. [#TGT:bbe5b9ddbc2430ff] Instead, the credit union must keep that pre-change provision in place until the loan has demonstrated sustained performance for a defined period. [#TGT:bbe5b9ddbc2430ff] The required duration is six months of performance following the rescheduling or recapitalisation, after which the credit union may reassess provisioning consistent with the applicable rules. [#TGT:bbe5b9ddbc2430ff] Accordingly, directors should regularly satisfy themselves that the credit union maintains the immediately pre-rescheduling (or pre-recapitalisation) provision throughout that six-month performance window as part of their oversight of accurate compliance with Rules 3.11 and 3.12. [#SRC:837cf352ecff942f] [#TGT:bbe5b9ddbc2430ff]", "source_text": "The PRA expects that all directors regularly satisfy themselves that their credit union accurately complies with the provisioning requirements in Rules 3.11 and 3.12 of the Credit Unions Part of the PRA Rulebook.", "target_text": "Where a delinquent loan is rescheduled or the arrears capitalised, the provision a credit union is required to make immediately prior to the rescheduling or recapitalisation must be maintained until the loan has performed for six months.", "source_passage_id": "837cf352ecff942f", "target_passage_id": "bbe5b9ddbc2430ff", "method": "DPEL", "persona": "professional"}
{"item_id": "8644b3b408b42603", "question": "If a firm trades cash equities or cash bonds (which can create settlement risk even though they don’t attract counterparty credit risk), what happens if the firm doesn’t manage settlement risk well for products outside its advanced CCR model and still uses zero capital for that risk?", "gold_answer": "If the firm is dealing in products like cash equities or cash bonds—examples of products that can create settlement risk without attracting counterparty credit risk—the firm still needs to manage the settlement risk effectively. [#TGT:5059cf1db1f509c9] When that settlement risk comes from products outside the scope of an advanced CCR model, and the firm’s settlement-risk management is not adequate, the PRA may question whether it is appropriate for the firm to apply a zero capital requirement to that settlement risk. [#SRC:6c6326c6d1c86320] Adequate management is illustrated by controls such as pre-deal checking, defined limit frameworks, and appropriate reporting; weaknesses in these kinds of measures are the type of situation in which the PRA may intervene. [#SRC:6c6326c6d1c86320] If the PRA does challenge the zero capital approach, it can require the firm to hold additional capital under Pillar 2 to address the settlement risk. [#SRC:6c6326c6d1c86320] In other words, the fact that these products’ settlement risk does not attract counterparty credit risk does not, by itself, prevent a Pillar 2 capital add-on if settlement-risk controls are not strong for exposures outside the advanced CCR model. [#TGT:5059cf1db1f509c9]", "source_text": "Where firms do not adequately manage settlement risk arising from products outside the scope of an advanced CCR model 13 (eg through pre-deal checking, defined limit frameworks, appropriate reporting), the PRA may challenge the appropriateness of a zero capital requirement for such risk and require firms to hold additional capital under Pillar 2.", "target_text": "13. This would include products (eg cash equities and cash bonds) that can result in settlement risk that does not attract counterparty credit risk.", "source_passage_id": "6c6326c6d1c86320", "target_passage_id": "5059cf1db1f509c9", "method": "DPEL", "persona": "basic"}
{"item_id": "70a3b5f3cf40b475", "question": "If I’m checking the SoP links to EIOPA materials, do I need to look at EIOPA updates made after the transition period, and what should I do about older Guidelines and Recommendations from predecessor committees that aren’t in the appendices?", "gold_answer": "For SoP purposes, you should rely on the EIOPA Guidelines and Recommendations that were in place at the end of the transition period, using the SoP links, and you should not treat later EIOPA changes or new EIOPA materials issued after that point as relevant to the SoP. [#TGT:6e9c30ab0bba7980] However, you also need to recognize that the appendices are not a complete inventory, so the fact that something is missing from the lists does not mean it can be ignored. [#SRC:fa6efa5299a687b0] Specifically, Guidelines and Recommendations made by predecessor committees to the ESAs may be absent from the appendices, yet firms and FMIs are expected to continue complying with them where relevant. [#SRC:fa6efa5299a687b0] The key limiter is that this continuation expectation does not apply if those predecessor materials have been revoked or replaced—either by later Guidelines and Recommendations or by other legislation. [#SRC:fa6efa5299a687b0] Putting both points together: use the SoP links as the Bank and PRA’s acknowledged EIOPA source for end-of-transition materials, but separately assess any relevant predecessor-committee materials that may not appear in the appendices, unless they have been revoked or superseded. [#TGT:6e9c30ab0bba7980] [#SRC:fa6efa5299a687b0]", "source_text": "The lists in Appendices 1 to 3 are not exhaustive. For example, Guidelines and Recommendations that were made by the predecessor committees 2 to the ESAs are not included on this list but firms and FMIs should continue, where relevant, to comply with them, unless they have been revoked or superseded by later Guidelines and Recommendations, or by other legislation.", "target_text": "Links to EIOPA Guidelines and Recommendations in place as at the end of the transition period are available below. Changes to existing EU Guidelines and Recommendations, and new Guidelines and Recommendations, issued by EIOPA after the end of the transition period are not relevant for the purposes of this SoP. The Bank and PRA acknowledge EIOPA as the source of these materials.", "source_passage_id": "fa6efa5299a687b0", "target_passage_id": "6e9c30ab0bba7980", "method": "DPEL", "persona": "basic"}
{"item_id": "e80cada23efc01c3", "question": "When determining the amount of the long-term insurance liability for each contract, under what circumstances may a retrospective calculation be used instead of the default prospective calculation, and what demonstration (if any) is required to justify that choice?", "gold_answer": "The default position is that the amount of the long-term insurance liability is to be calculated prospectively for each contract, meaning the starting assumption is a prospective calculation on a contract-by-contract basis. [#SRC:72c3af495575a5fb] A retrospective calculation is permitted only as an exception to that default, and only in limited circumstances tied to the feasibility and prudence of the prospective approach. [#TGT:30f622a929df3844] Specifically, a retrospective calculation may be used where a prospective method cannot be applied to a particular type of contract or benefit, which links the contract-level determination requirement to a contract/benefit-type limitation on method selection. [#SRC:72c3af495575a5fb] [#TGT:30f622a929df3844] Alternatively, even if a prospective method could be applied, a retrospective calculation may be used where it can be demonstrated that the liabilities produced would be no lower than the amount that would be required by a prudent prospective calculation; in that case, the justification hinges on demonstrating a non-lower outcome relative to a prudent prospective benchmark. [#TGT:30f622a929df3844] In all cases, the prospective calculation remains the baseline method for determining the long-term insurance liability for each contract, and the retrospective approach is only available within the stated exception conditions. [#SRC:72c3af495575a5fb] [#TGT:30f622a929df3844]", "source_text": "Subject to 7.2 , 7.3 and 7.4 , the amount of the long-term insurance liability must be determined for each contract by a prospective calculation.", "target_text": "A retrospective calculation may only be applied to determine the liabilities where a prospective method cannot be applied to a particular type of contract or benefit, or where it can be demonstrated that the resulting amount of liabilities would be no lower than would be required by a prudent prospective calculation.", "source_passage_id": "72c3af495575a5fb", "target_passage_id": "30f622a929df3844", "method": "DPEL", "persona": "professional"}
{"item_id": "1553e2bfdf80cc91", "question": "If a firm has big exposures to companies in its own group, what is the normal rule for how those exposures are treated, and what does the firm need to apply for if it wants a higher limit—plus which named document (with month and year) is pointed to for “Large Exposures”?", "gold_answer": "Normally, a firm’s exposures to entities in its own group are not treated as a special category; they are generally treated like exposures to a third party and therefore are subject to the large exposure limits. [#SRC:27a742d1f4627dc1] If the firm wants to use a higher large exposure limit for certain entities within its group, it can do so only by applying to the PRA for a non-core large exposures group permission, and the higher limit is available only where those group entities meet the relevant conditions tied to that permission. [#SRC:27a742d1f4627dc1] The text also points to a specific supervisory statement for the large exposures topic: SS16/13, called ‘Large Exposures’, dated June 2018. [#TGT:998aae35b45397cf] Putting these points together, the compliance approach is to treat intra-group exposures as if they were to an outside counterparty unless the PRA grants the non-core large exposures group permission, and to use the referenced SS16/13 ‘Large Exposures’ (June 2018) as the named supervisory statement associated with this large exposures framework. [#SRC:27a742d1f4627dc1] [#TGT:998aae35b45397cf]", "source_text": "A firm’s exposures to entities in its own group are generally treated as exposures to a third party and are subject to large exposure limits. Firms can however apply to the PRA for a non-core large exposures group permission, which allows firms to apply a higher large exposure limit to certain entities within their group provided these entities meet certain conditions. 45", "target_text": "45. SS16/13 ‘Large Exposures’, June 2018: https://www.bankofengland.co.uk/prudential-regulation/publication/2013/large-exposures-ss .", "source_passage_id": "27a742d1f4627dc1", "target_passage_id": "998aae35b45397cf", "method": "DPEL", "persona": "basic"}
{"item_id": "e8702e16126ff3d4", "question": "If a controller or proposed controller is an investment manager buying or selling listed shares as part of fund management and is following directions 2.1 and 2.3, what form can they use, and what does the section 178 notice need to include and be sent with?", "gold_answer": "For an investment manager in this listed-shares fund management situation, the PRA allows use of a specific Controller’s form, and the section 178 notice must be completed to match the information and document requirements of the relevant Controller’s Form. [#SRC:3d54441b14fbefda] [#TGT:6dd8365d28ebc407] The PRA’s direction for this context is that where a controller or proposed controller that is an investment manager is complying with the directions in 2.1 and 2.3 in connection with acquiring or disposing of listed shares in the course of its fund management activity, it may use the Controller’s form at 6.5. [#SRC:3d54441b14fbefda] Separately, the PRA directs that a section 178 notice submitted to the PRA in accordance with section 178(1) of FSMA must contain the information and be accompanied by the documents required by the Controller’s Form approved for the relevant application. [#TGT:6dd8365d28ebc407] Putting these together, the permitted form in the investment-manager listed-shares case is the Controller’s form at 6.5, and the notice should include the information and supporting documents that the applicable Controller’s Form requires. [#SRC:3d54441b14fbefda] [#TGT:6dd8365d28ebc407]", "source_text": "Where a controller or proposed controller that is an investment manager is complying with the directions in 2.1 and 2.3 in connection with the acquiring or disposal of listed shares in the course its fund management activity, the PRA directs that it may use the Controller’s form at 6.5 .", "target_text": "The PRA directs that a section 178 notice submitted to the PRA in accordance with section 178(1) of FSMA must contain the information and be accompanied by such documents as are required by the Controller’s Form approved for the relevant application.", "source_passage_id": "3d54441b14fbefda", "target_passage_id": "6dd8365d28ebc407", "method": "DPEL", "persona": "basic"}
{"item_id": "3a622780ced5dd99", "question": "For a third country CRR firm, how should responsibility for allocating all third country CRR firm prescribed responsibilities be handled, and to whom must those prescribed responsibilities be allocated (in terms of the type of persons who perform the roles)?", "gold_answer": "A third country CRR firm must ensure there is clear responsibility for carrying out the allocation of all third country CRR firm prescribed responsibilities, and that the allocation itself is made to appropriate individuals. Specifically, the firm must have responsibility assigned for the allocation of all third country CRR firm prescribed responsibilities in accordance with 3.5 (PR E). [#SRC:09fb22f0b9fd2ac5] In addition, the firm must allocate each of the third country CRR firm prescribed responsibilities to one or more persons who perform the relevant functions (i.e., the allocation is not left unassigned or allocated to no one). [#TGT:f7c5508f92091364] Read together, this means the firm needs both (i) an identified responsibility for managing the allocation process for all prescribed responsibilities (including following the referenced allocation framework), and (ii) an outcome where each prescribed responsibility is actually allocated to at least one person who performs the applicable role(s). [#SRC:09fb22f0b9fd2ac5] [#TGT:f7c5508f92091364] This combination addresses both governance over the allocation exercise (who is responsible for ensuring it happens) and the substantive requirement that every prescribed responsibility is assigned to one or more qualifying persons who perform the relevant duties. [#SRC:09fb22f0b9fd2ac5] [#TGT:f7c5508f92091364]", "source_text": "(8) responsibility for the allocation of all third country CRR firm prescribed responsibilities in accordance with 3.5 (PR E) ;", "target_text": "A third country CRR firm must allocate each of the third country CRR firm prescribed responsibilities to one or more persons who perform:", "source_passage_id": "09fb22f0b9fd2ac5", "target_passage_id": "f7c5508f92091364", "method": "DPEL", "persona": "professional"}
{"item_id": "daf1fb0651ef2daa", "question": "If a firm has already done end-to-end mapping of its important business services under Chapter 4, how can it use that work to help write down what it needs (people, processes, technology, facilities and information) to deliver each important business service, including intragroup and other dependencies?", "gold_answer": "The firm can use its Chapter 4 end-to-end mapping as a practical foundation for the documentation it must produce for each important business service. [#SRC:47c57621ff7696dd] The required documentation must identify the necessary people, processes, technology, facilities and information needed to deliver each important business service, so the firm should structure its write-up to capture those items for every service. [#TGT:b33e7a291295fbdf] It may then extend or align that same mapping output to document and map intragroup and other dependencies, so that dependencies are recorded alongside (and connected to) the people, processes, technology, facilities and information that enable delivery. [#SRC:47c57621ff7696dd] [#TGT:b33e7a291295fbdf] Put another way, the firm should treat the end-to-end mapping under Chapter 4 as the mechanism to connect “what is necessary to deliver the service” with “which intragroup and other dependencies support those necessary elements,” ensuring both are documented for each important business service. [#TGT:b33e7a291295fbdf] [#SRC:47c57621ff7696dd]", "source_text": "Firms may also leverage their end-to-end mapping of important business services under Chapter 4 of the Operational Resilience – CRR Firms and Operational Resilience – Solvency II Parts of the PRA Rulebook to document and map their intragroup and other dependencies.", "target_text": "As part of its obligation under 3.1 , a firm must identify and document the necessary people, processes, technology, facilities and information required to deliver each of its important business services .", "source_passage_id": "47c57621ff7696dd", "target_passage_id": "b33e7a291295fbdf", "method": "DPEL", "persona": "basic"}
{"item_id": "00dfd182c50cd149", "question": "If a composite firm keeps separate accounts for its long-term insurance business and its general insurance business, what does it have to write up from those accounts about eligible own funds and the notional MCR for each business?", "gold_answer": "Where a composite firm maintains separate accounts for its long-term insurance business and its general insurance business so that the results and sources for each activity are shown separately, it must also produce a statement that uses those accounts as its foundation. [#TGT:eac60971cab72fc0] In that statement, the firm must identify the eligible own funds that cover the notional long-term insurance MCR and, separately, the eligible own funds that cover the notional general insurance MCR. [#SRC:0b09948a10ceade3] In practical terms, the separation of accounts across the two activities should be reflected in the statement’s structure: it should clearly distinguish the long-term insurance side from the general insurance side rather than blending them into one combined presentation. [#TGT:eac60971cab72fc0] The minimum required elements are therefore two distinct identifications—one for eligible own funds covering the notional long-term insurance MCR and one for eligible own funds covering the notional general insurance MCR—each prepared on the basis of the accounts. [#SRC:0b09948a10ceade3]", "source_text": "The firm must prepare a statement on the basis of the accounts referred to in 3.2 identifying the eligible own funds covering the notional long-term insurance MCR and the notional general insurance MCR , respectively.", "target_text": "A composite firm must maintain separate accounts for each of its long-term insurance business and its general insurance business to show the sources of the results for each activity separately.", "source_passage_id": "0b09948a10ceade3", "target_passage_id": "eac60971cab72fc0", "method": "DPEL", "persona": "basic"}
{"item_id": "3429c26b6ec0b661", "question": "When increasing a firm’s exposure amount to assets under the rule that adds in dependants’ exposures, how must the exposure of each dependant be determined, and how does that determination feed into the firm-level increase?", "gold_answer": "To increase the firm’s exposure to a given asset description, the firm must add an amount that represents any exposure its dependants have to assets of that same description, but the dependant exposures used for that increase must be computed in a specific way. [#TGT:250709f3ef53e2f6] In particular, for the purposes of the firm-level mechanism that brings dependants into the exposure amount, each dependant’s exposure is not taken as a raw figure; instead, it must be calculated by applying the same asset-exposure determination provisions (18 to 22) to that dependant as though the dependant were itself a firm to which those provisions apply, regardless of whether it actually is. [#SRC:d0975ff530ed6e30] This creates a two-step linkage: first, determine the firm’s own exposure to assets in accordance with 18 to 22; second, determine each dependant’s exposure to assets of that description using 18 to 22 applied to the dependant on a “treat as a firm” basis, and then increase the firm’s amount by the resulting dependant exposure amount (if any). [#TGT:250709f3ef53e2f6] [#SRC:d0975ff530ed6e30]", "source_text": "For the purposes of 23.1 , the exposure of each dependant must be calculated by applying 18 to 22 to that dependant as if it were a firm to which those provisions apply (whether it is or not).", "target_text": "Subject to 23.2 and 23.3 , the amount of the firm’s exposure to assets determined in accordance with 18 to 22 must be increased by an amount representing the exposure , if any, of the firm’s dependants to assets of that description.", "source_passage_id": "d0975ff530ed6e30", "target_passage_id": "250709f3ef53e2f6", "method": "DPEL", "persona": "professional"}
{"item_id": "df5d3cff06f3fea5", "question": "What does a critical third party need to be able to show regulators, and how do the playbook checks and exercises (including the 12-month and biennial timing) help prove that?", "gold_answer": "A critical third party must be able to demonstrate to the regulators that it can comply with this Part, and one way to do that is to point to how it meets the incident management playbook obligations described in the Part. [#TGT:2d682f43e1f6ff70] Specifically, it has to assess the effectiveness of its incident management playbook on a regular basis, and that regular assessment includes running an appropriate playbook exercise with a representative sample of the firms to which it provides systemic third party services. [#SRC:6fb580eef1e5447d] The timing of that exercise is also part of what should be demonstrated: the first exercise must be completed within 12 months of the critical third party being designated by the Treasury, and then the exercise must occur at least every two years after that. [#SRC:6fb580eef1e5447d] To make the demonstration meaningful to regulators, the critical third party should be able to present evidence that these assessments and exercises were carried out in line with the required scope (representative sample) and schedule (12 months, then biennially). [#TGT:2d682f43e1f6ff70] [#SRC:6fb580eef1e5447d]", "source_text": "As part of its obligation under 5.1 , a critical third party must assess the effectiveness of its incident management playbook regularly, including undertaking an appropriate incident management playbook exercise with a representative sample of the firms to which it provides systemic third party services within 12 months of the critical third party being designated by the Treasury and at least biennially thereafter.", "target_text": "A critical third party must be able to demonstrate to the regulators its ability to comply with this Part.", "source_passage_id": "6fb580eef1e5447d", "target_passage_id": "2d682f43e1f6ff70", "method": "DPEL", "persona": "basic"}
{"item_id": "cae25624f8120f3a", "question": "How must institutions map a derivative transaction that has more than one material risk driver when the primary (or most material, within a given risk category) risk driver is a climatic conditions variable, and the other material risk driver(s) fall into different risk categories?", "gold_answer": "Institutions must treat the climatic conditions variable as requiring mapping to the commodity risk category, while also applying the multi-risk-driver mapping approach for derivative transactions with more than one material risk driver. [#SRC:d444b5b1871ca35e] [#TGT:28d975e9bccdd9ad] In practice, this means the transaction is not mapped to a single category only; instead, it is mapped across all relevant risk categories that contain at least one material risk driver, including commodity where the climatic conditions variable is the primary or most material driver in a given risk category. [#SRC:d444b5b1871ca35e] [#TGT:28d975e9bccdd9ad] For the commodity mapping specifically, the climatic conditions variable is the basis for mapping the transaction to the commodity risk category. [#SRC:d444b5b1871ca35e] For the other risk categories implicated by the remaining material risk drivers, the institution must map the transaction once to each such risk category, using the most material risk driver within each category as the basis for that category’s mapping. [#TGT:28d975e9bccdd9ad] If, however, all material risk drivers happen to fall within the same risk category, the institution maps the transaction only once to that category based on the most material driver—while still recognizing that a climatic conditions variable, when it is the primary or most material driver, points to commodity as the relevant category. [#TGT:28d975e9bccdd9ad] [#SRC:d444b5b1871ca35e]", "source_text": "(b) where the primary risk driver of a transaction, or the most material risk driver in a given risk category for transactions referred to in paragraph 3 , is a climatic conditions variable, institutions shall map the transaction to the commodity risk category.", "target_text": "By way of derogation from paragraph 2 , institutions shall map derivative transactions that have more than one material risk driver to more than one risk category. Where all the material risk drivers of one of those transactions belong to the same risk category, institutions shall only be required to map that transaction once to that risk category on the basis of the most material of those risk drivers. Where the material risk drivers of one of those transactions belong to different risk categories, institutions shall map that transaction once to each risk category for which the transaction has at least one material risk driver, on the basis of the most material of the risk drivers in that risk category.", "source_passage_id": "d444b5b1871ca35e", "target_passage_id": "28d975e9bccdd9ad", "method": "DPEL", "persona": "professional"}
{"item_id": "0bb02cec20fda4af", "question": "For a firm using an internal model, what quarterly submission to the PRA is required for internal model changes, and what additional materials and rulebook references must be followed when preparing that submission?", "gold_answer": "A firm that uses an internal model must make a quarterly submission to the PRA using template QMC.01, and that submission must cover model changes together with supporting qualitative/narrative material prepared in line with the relevant rulebook instructions and reporting provisions. [#TGT:96395cb1453e2aa2] Specifically, the firm must submit quarterly template QMC.01 and include information on model changes plus supporting qualitative information, following the instructions in section QMC.01 of Chapter 10 (for the template referenced in Chapter 9). [#TGT:96395cb1453e2aa2] In addition, the quarterly reporting obligation described for internal model change governance requires the firm to provide a quarterly summary of both minor and major model changes to the PRA using the QMC.01 template, accompanied by supporting narrative documentation, and to do so in line with Article 6(3) of Chapter 2A of the Reporting Part in the PRA Rulebook. [#SRC:2de692b032a74b5d] Taken together, this means the quarterly QMC.01 filing is not limited to a bare template: it must be completed with the specified model-change information and the required qualitative/narrative support, and it must be prepared consistently with both the template instructions (Chapter 10 section QMC.01) and the reporting provision that frames the quarterly summary requirement (Article 6(3) of Chapter 2A of the Reporting Part). [#TGT:96395cb1453e2aa2] [#SRC:2de692b032a74b5d]", "source_text": "It is important that the internal model change policy is of a good standard. Firms should consider all the relevant PRA Rulebook requirements and the EIOPA Guidelines when developing and maintaining their internal model change policy. Firms are required to report a quarterly summary of minor and major model changes to the PRA using the QMC.01 template and supporting narrative documentation, in accordance with Article 6(3) of Chapter 2A of the Reporting Part in the PRA Rulebook.", "target_text": "Firms using an internal model must submit to the PRA quarterly template QMC.01 of Chapter 9 , specifying information on model changes and supporting qualitative information, in accordance with the instructions set out in section QMC.01 of Chapter 10 .", "source_passage_id": "2de692b032a74b5d", "target_passage_id": "96395cb1453e2aa2", "method": "DPEL", "persona": "professional"}
{"item_id": "c54eaac597385db2", "question": "How should a firm populate and structure the single customer view and exclusions view when certain data items in the required information set are not held by the firm or are not applicable, given the obligation that each view must contain all information set out in the table?", "gold_answer": "A firm should build each single customer view (SCV) and exclusions view so that it includes the full set of fields corresponding to the required information, while leaving particular fields blank only where the firm does not hold the data or the data item does not apply. [#TGT:ad978d8ce164b1e0] Where data required for inclusion are not held or are not applicable, the firm should keep the relevant fields present in the SCV and exclusions view file but leave those fields empty, so the files remain standard in length. [#SRC:697a55e1d316e0fa] The firm should also maintain a consistent field sequence: fields should always appear in the same order as set out in Depositor Protection 12.9, even when some fields are empty. [#SRC:697a55e1d316e0fa] At the same time, the firm must complete all fields that are mandatory, and must also complete fields where the data are applicable and held by the firm; completion of all fields is mandatory unless the field is indicated as not applicable or not held (where not mandatory). [#SRC:697a55e1d316e0fa] In practice, this means the firm satisfies the requirement that each SCV and exclusions view contains all the information set out in the table by ensuring every required field exists in the file structure, while using empty values only for permitted “not held/not applicable” cases and fully populating mandatory and applicable-held data items. [#TGT:ad978d8ce164b1e0] [#SRC:697a55e1d316e0fa]", "source_text": "Where firms do not hold the data required to be included in the SCV or exclusions view file or the data are not applicable, corresponding fields in the SCV and exclusions view file should remain empty. Even if these fields are empty, the PRA expects these fields to remain in the SCV file and the exclusions view file, so that the files are standard in length. Fields should always appear in the same order set out in Depositor Protection 12.9 . Completion of all fields is mandatory unless otherwise indicated (ie not applicable or not held by the firm (where not mandatory)). Firms must complete all fields where data are mandatory, or where applicable and held by the firm.", "target_text": "A firm must ensure that each single customer view and exclusions view contains all the information set out in the table below.", "source_passage_id": "697a55e1d316e0fa", "target_passage_id": "ad978d8ce164b1e0", "method": "DPEL", "persona": "professional"}
{"item_id": "41c8988e0f8349d3", "question": "If an institution checks its derivatives business size every month using month-end data and it is under the thresholds, can it use the Section 5 method for exposure value—and what happens if it does not meet the Article 273a(2) conditions?", "gold_answer": "Being under the thresholds based on the required monthly check is necessary but not sufficient for using the Section 5 method; the institution must also meet the Article 273a(2) conditions. [#TGT:76ff5419b175628d] The rule allows an institution to calculate the exposure value of its derivative positions using the method in Section 5 only when, subject to the restriction in Article 273b(2), it has assessed the size of its on- and off-balance-sheet derivative business on a monthly basis using data as of the last day of the month and found that size to be no more than both thresholds referenced. [#TGT:76ff5419b175628d] However, there is a separate prohibition: if the institution does not meet the conditions set out in Article 273a(2), it must not use the method in Section 5. [#SRC:9eb9559cd3b01598] This means that even if the monthly, month-end-data assessment shows the business is within the thresholds, the institution still cannot use Section 5 if it fails Article 273a(2). [#SRC:9eb9559cd3b01598] In practice, the institution should treat the monthly threshold assessment and the Article 273a(2) conditions as cumulative gates, with the Article 273b(2) restriction also applying where relevant. [#TGT:76ff5419b175628d]", "source_text": "An institution which does not meet the conditions set out in Article 273a(1) shall not use the method set out in Section 4 . An institution which does not meet the conditions set out in Article 273a(2) shall not use the method set out in Section 5 .", "target_text": "Subject to the restriction set out in Article 273b(2) , an institution may calculate the exposure value of its derivative positions in accordance with the method set out in Section 5 , provided that the size of its on- and off-balance-sheet derivative business is equal to or less than both of the following thresholds on the basis of an assessment carried out on a monthly basis using the data as of the last day of the month :", "source_passage_id": "9eb9559cd3b01598", "target_passage_id": "76ff5419b175628d", "method": "DPEL", "persona": "basic"}
{"item_id": "4a85f884c0ae3a7e", "question": "If societies are merging by amalgamation and are getting ready to submit the formal application to the PRA for approval of a Schedule 16 Statement, what should they have already cleared with the FCA and PRA, and what exactly must they send (and how many copies) when they apply to the PRA for confirmation under Section 93(2) of the 1986 Act?", "gold_answer": "Before making the formal application to the PRA for approval of a Schedule 16 Statement, the societies should expect that PRA staff will already have reviewed and commented on drafts of the Statement, taking into account drafts of the Instrument of Transfer (or amalgamation agreement) and the prudential information referenced as preliminary matters. [#TGT:b82c2ae32466a535] For an amalgamation specifically, they should also have cleared the proposed Memorandum and Rules of the successor society with both the FCA and the PRA, aligning the draft work on the Statement with the governance documents for the successor society. [#TGT:b82c2ae32466a535] The FCA’s role is that it must be satisfied about the proposed Rules, the proposed Memorandum, and the name of the successor society, so the amalgamating societies are advised to clear drafts of the proposed Rules and Memorandum with the FCA early. [#SRC:4c98e92939aed724] Then, when applying to the PRA for confirmation under Section 93(2) of the 1986 Act, the societies must send three signed copies of the Rules and Memorandum to the PRA and also to the FCA. [#SRC:4c98e92939aed724] This ties the early clearance step to the later requirement for signed, multi-copy submissions to both regulators. [#TGT:b82c2ae32466a535] [#SRC:4c98e92939aed724]", "source_text": "In the case of an amalgamation, the FCA is required to be satisfied as regards the proposed Rules, Memorandum and name of the successor society. The amalgamating societies are, therefore, advised to clear drafts of the proposed Rules and Memorandum with the FCA at an early stage (see paragraph 3.96 ). When they apply to the PRA for confirmation under Section 93(2) of the 1986 Act, the amalgamating societies must send three signed copies of the Rules and Memorandum to the PRA and the FCA (Section 93(2)(d)). If the FCA is satisfied on these matters it will, upon confirmation by the PRA , register the successor society and issue to it a certificate of incorporation specifying the date (the specified date) from which the incorporation takes effect, and will return to it one copy each of the Rules and Memorandum together with a certificate of registration. Copies are placed on the public file of the successor society.", "target_text": "A society’s formal application to the PRA for approval of a Schedule 16 Statement is likely to be the culmination of many weeks of discussion with the PRA’s staff who will have reviewed and commented upon a draft or successive drafts of the Statement, having had regard also to drafts of the Instrument of Transfer (or amalgamation agreement) and the prudential information described in ‘Preliminary matters’ . Societies should also have cleared any proposed Rule changes or, in the case of an amalgamation, the proposed Memorandum and Rules of the successor society, with the FCA and the PRA.", "source_passage_id": "4c98e92939aed724", "target_passage_id": "b82c2ae32466a535", "method": "DPEL", "persona": "basic"}
{"item_id": "f4b5f225c009a618", "question": "When a representer submits a written representation to the PRA, what procedural information must the PRA provide to that representer, and how does that relate to the stated purpose of the appendix for those making written representations and/or participating in oral confirmation hearings?", "gold_answer": "A representer who submits a written representation to the PRA should expect two linked procedural outcomes: (1) the PRA will confirm it has received the submission, and (2) the PRA will provide procedural guidance by sending the representer a copy of Appendix 5 on merger confirmation procedures. [#SRC:8e78e2017ace2c0e] This aligns with the stated function of the appendix as a document intended for people making written representations to the PRA and/or those involved in oral confirmation hearings, because it is meant to describe the procedures the PRA plans to follow. [#TGT:9361b73623bf63a6] In practical terms, the appendix operates as the PRA’s procedural roadmap for representers (and hearing participants), and the PRA’s act of sending it to each representer ensures that those engaging through written representations have access to that roadmap at the point their representation is received and acknowledged. [#SRC:8e78e2017ace2c0e][#TGT:9361b73623bf63a6] Separately, the PRA will also circulate written representations to the societies concerned and give those societies a chance to comment, which is part of the overall procedure the appendix is intended to set out. [#SRC:8e78e2017ace2c0e][#TGT:9361b73623bf63a6]", "source_text": "The PRA will acknowledge the receipt of each representation or notice and will send a copy of Appendix 5 , on merger confirmation procedures, to each representer. It will send copies of all written representations to the societies concerned and will afford them an opportunity to comment on them.", "target_text": "This appendix is for the use of those making written representations to the PRA and/or those participating in oral confirmation hearings. It sets out the procedures which the PRA intends to follow.", "source_passage_id": "8e78e2017ace2c0e", "target_passage_id": "9361b73623bf63a6", "method": "DPEL", "persona": "professional"}
{"item_id": "da60819c590e205c", "question": "Where 2.1(3) applies to a group, how must a relevant insurance group undertaking treat a parent undertaking that is an insurance holding company without its head office in the UK or Gibraltar (or a third country insurance or reinsurance undertaking) when calculating group solvency for the purpose of 20.1, and how does that treatment align with the fact that modules 4 to 14, 16 to 19 and External Audit 2 to 4 apply at the level of that parent undertaking (unless an exception applies)?", "gold_answer": "In a group to which 2.1(3) applies, a relevant insurance group undertaking must, solely for the purpose of calculating group solvency for 20.1, treat the parent undertaking as if it were a UK Solvency II firm to which 2.1(1)(a) applies, even where that parent is an insurance holding company without its head office in the UK or Gibraltar, or is a third country insurance undertaking or third country reinsurance undertaking. [#SRC:9faaabced2ba31fb] This calculation-only re-characterisation sits alongside the separate rule that, when 2.1(3) applies, modules 4 to 14, 16 to 19 and External Audit 2 to 4 apply (with necessary changes) at the level of that same type of parent undertaking, unless an exception applies. [#TGT:4b76a4f92f32f4d8] Practically, this means the group solvency computation for 20.1 is performed on the basis that the parent is treated as within the UK Solvency II firm perimeter for that computation, while the broader set of specified modules and external audit provisions are also applied at the parent level (subject to the stated “unless” carve-out). [#SRC:9faaabced2ba31fb] [#TGT:4b76a4f92f32f4d8]", "source_text": "When calculating the solvency of a group falling within 2.1(3) for the purpose of 20.1 , a relevant insurance group undertaking must treat the parent undertaking (being an insurance holding company which does not have its head office in the UK or Gibraltar or a third country insurance undertaking or a third country reinsurance undertaking ), solely for the purposes of that calculation, as a UK Solvency II firm to which 2.1(1)(a) applies.", "target_text": "When 2.1(3) applies, 4 to 14 , 16 to 19 and External Audit 2 to 4 apply with any necessary changes at the level of the insurance holding company or mixed financial holding company which does not have its head office in the UK or Gibraltar, third country insurance undertaking or third country reinsurance undertaking unless:", "source_passage_id": "9faaabced2ba31fb", "target_passage_id": "4b76a4f92f32f4d8", "method": "DPEL", "persona": "professional"}
{"item_id": "4d814cc0f983bd44", "question": "If the data needed for 4.13(4) isn’t available or isn’t reliable, can a firm make up data when setting the stressed FS floor, and what limits apply so the floor still meets the PRA’s minimum expectations?", "gold_answer": "Yes, a firm can use constructed data when some of the data referred to in 4.13(4) is missing or unreliable, but it must do so within specific limits and still meet the PRA’s expectations for the stressed FS floor. [#TGT:5f5585242ebb290e] The constructed data must be built on prudent assumptions and must be based on available and reliable data relating to the previous 30 years, so the firm cannot construct inputs without grounding them in that historical, reliable dataset. [#TGT:5f5585242ebb290e] At the same time, the PRA expects firms to maintain a floor (a minimum FS level at the appropriate point in the calculation) based on long-term average spreads as part of modelling stressed FS, and at a minimum to reapply the floor methodology and calibration described in Matching Adjustment 4.11 to 4.15. [#SRC:c25a4960dc77cc1d] If the firm changes the floor (including because it used constructed data), the firm should be able to justify those changes. [#SRC:c25a4960dc77cc1d] The firm also should not allow the change to reduce the calibration below what would have been produced by reapplying the methodology and calibration used to calculate the TPs, so the constructed-data approach must not be used to push the floor lower than that baseline. [#SRC:c25a4960dc77cc1d]", "source_text": "The PRA expects firms to maintain a floor (ie a minimum level of FS at the appropriate point of the calculation) based on long-term average spreads as part of their modelling of the stressed FS. As a minimum, the PRA expects firms to reapply the methodology and calibration of the floor as set out in Matching Adjustment 4.11 to 4.15 . If any changes are made to the floor, the PRA expects these changes to be justified. They should not result in a calibration below that which would have been obtained by re-applying the methodology and calibration used to calculate the TPs.", "target_text": "Where part of the data referred to in 4.13(4) is not available or where the available data is not reliable, constructed data based on prudent assumptions may be used; and the constructed data must be based on available and reliable data relating to the previous 30 years.", "source_passage_id": "c25a4960dc77cc1d", "target_passage_id": "5f5585242ebb290e", "method": "DPEL", "persona": "basic"}
{"item_id": "3bd832c6ab8197f8", "question": "If someone has normal eligible deposits and also a temporary high balance, what are the maximum amounts that can be paid, and when is there no limit for the temporary high balance?", "gold_answer": "You need to treat the person’s ordinary eligible deposits and any temporary high balance as separate categories with different maximums. For the person’s aggregate eligible deposits, the maximum compensation sum payable is £120,000, although the text notes that extra compensation may be payable in cases that fall under 4.3 or 4.4. [#SRC:336f75f8cdcde56e] For a temporary high balance, the maximum compensation sum is £1,400,000, and that maximum is stated to apply subject to 4.4. [#TGT:b5fbb2a524d9ce87] There is also a specific situation where the temporary high balance has no cap at all: if the temporary high balance comes from a payment connected with personal injury or incapacity, then no limit applies to the compensation payable for that temporary high balance. [#TGT:b5fbb2a524d9ce87] Putting these together, a person could be limited to £120,000 for their aggregate eligible deposits while still being able to claim temporary high balance compensation up to £1,400,000 (or without limit in the personal injury or incapacity payment case), with both the aggregate-deposit and temporary-high-balance rules referencing 4.4 as a relevant condition. [#SRC:336f75f8cdcde56e] [#TGT:b5fbb2a524d9ce87]", "source_text": "The maximum compensation sum payable for the aggregate eligible deposits of each depositor is £120,000, save that additional compensation may be payable in cases to which 4.3 or 4.4 apply.", "target_text": "Subject to 4.4 , the maximum compensation sum payable for a temporary high balance is £1,400,000, save that no limit shall apply to the compensation payable for a temporary high balance arising from a payment in connection with personal injury or incapacity.", "source_passage_id": "336f75f8cdcde56e", "target_passage_id": "b5fbb2a524d9ce87", "method": "DPEL", "persona": "basic"}
{"item_id": "f58675784731de79", "question": "If the PRA external audit rules apply to an undertaking’s SFCR, does the auditor need to cover how big the matching adjustment’s effect is, and how does the example about calculating the impact of changing the MA to zero (and its link to Life Technical Provisions) help explain what must be in scope?", "gold_answer": "Yes. When the PRA’s external audit rules apply, the scale of the matching adjustment (MA)—i.e., the extent to which it affects technical provisions—is within the audit scope. [#SRC:428012445d83f28d] The reason given is that the MA’s impact sits within the SFCR “relevant elements” that external auditors are required to form a view on. [#SRC:428012445d83f28d] The target text provides a concrete illustration of what that means in practice: it identifies as a relevant element the quantification of how the undertaking’s financial position would be affected if the MA were changed to zero. [#TGT:a160cf63fb8299cf] That example helps connect the general “relevant elements” concept to a specific MA-related calculation that is expected to be covered. [#TGT:a160cf63fb8299cf] The target text also states that the MA directly affects Life Technical Provisions, and that those Life Technical Provisions are within scope of the External Audit rule, which aligns with the source’s focus on the MA’s impact on technical provisions as audit-scoped. [#TGT:a160cf63fb8299cf] [#SRC:428012445d83f28d] Taken together, these points indicate the auditor’s scope should include both the MA’s effect on technical provisions and the SFCR-relevant quantification of the “MA to zero” impact on financial position. [#SRC:428012445d83f28d] [#TGT:a160cf63fb8299cf]", "source_text": "The scale of the matching adjustment (ie the extent to which the MA impacts on technical provisions) is within scope of audit where the PRA’s external audit rules apply. 6 This reflects the fact that the impact of the MA falls within the ‘relevant elements’ that external auditors of the SFCR are required to form a view on. 7", "target_text": "7. For example, the quantification of the impact of a change to zero of the MA on that undertaking’s financial position is specified as a relevant element of the SFCR (External Audit 2.2(1) and Rules 3.4(1)(a) and (b) in the Reporting Part of the PRA Rulebook. In addition, the MA has a direct effect on Life Technical Provisions which are within scope of the External Audit rule.", "source_passage_id": "428012445d83f28d", "target_passage_id": "a160cf63fb8299cf", "method": "DPEL", "persona": "basic"}
{"item_id": "9603d188a6240488", "question": "If a merger plan includes payments to directors or other officers because they are losing their job or income, and it also includes bonus payments, what member votes are needed and where do the bonus votes have to appear if the bonus total is within the prescribed limit versus above it?", "gold_answer": "You need two coordinated member-approval tracks: a separate special resolution for the loss-of-office/loss-of-income compensation, and Merger Resolutions that include the required approval for bonus payments, with the scope of those Merger Resolutions depending on the prescribed-limit test. [#SRC:64a6d4e1a3eca833] If the merger terms provide for compensation to directors or other officers for loss of office or of income, the proposed payments must be approved by a separate special resolution. [#SRC:64a6d4e1a3eca833] Separately, members’ approval of bonus payments is required as part of the Merger Resolutions. [#TGT:9dfe512afd4bf0e8] To decide which societies’ Merger Resolutions must carry that bonus approval, you look at the total gross cost of the proposed bonus(es) without any adjustment for prospective corporation tax recovery. [#TGT:9dfe512afd4bf0e8] If that gross cost is within the prescribed limit, the bonus approval only needs to be included in each of the Merger Resolutions of the society whose funds are to be distributed. [#TGT:9dfe512afd4bf0e8] If it exceeds the prescribed limit, the bonus approval must be included in each of the Merger Resolutions of each participating society. [#TGT:9dfe512afd4bf0e8] This keeps the compensation vote separate while ensuring the bonus vote is placed in the correct Merger Resolutions based on the limit. [#SRC:64a6d4e1a3eca833] [#TGT:9dfe512afd4bf0e8]", "source_text": "If the terms of a merger include provision for the payment of compensation to directors or other officers for loss of office or of income, then the proposed payments must be approved by a separate special resolution. A further special resolution may also be required if there is to be a distribution to members which exceeds the limits described in paragraph 3.107 .", "target_text": "The members approval of bonus payments is required as part of the Merger Resolutions (see section 96(4) to (6) of the 1986 Act) and see paragraph 3.59 for the PRA’s view of what may constitute a bonus). If the total gross cost of the proposed bonus(es) (ie without any adjustment for prospective corporation tax recovery) is within the prescribed limit, then approval for it need only be included in each of the Merger Resolutions of the society whose funds are to be distributed. If it exceeds that limit then it must be included in each of the Merger Resolutions of each participating society. The prescribed limit was changed by the Building Societies (Mergers) (Amendment) Regulations SI 1995/1874 amending S1 1987/2005 and now is:", "source_passage_id": "64a6d4e1a3eca833", "target_passage_id": "9dfe512afd4bf0e8", "method": "DPEL", "persona": "basic"}
{"item_id": "177ed41f94126d47", "question": "If a firm is planning a solvent exit, what does it need to do about paying back or transferring deposits and making sure it has enough time and resources, and what extra thing should it consider if it is a building society (given that a solvent exit might not end in liquidation)?", "gold_answer": "In a solvent exit, the firm is expected to stop its PRA-regulated activities while staying solvent, and it should plan to transfer and/or repay all deposits as part of that exit. [#SRC:a9dcecc8a5a3b33a] The planning should include enough time and resources to allow the firm to meet its liabilities when they fall due while it carries out the deposit transfers and/or repayments, and the firm should anticipate that the solvent exit ends when deposit-taking is removed from its Part 4A permission or when its Part 4A permission is cancelled (removal of the firm’s Part 4A PRA permission). [#SRC:a9dcecc8a5a3b33a] Separately, the firm should recognize that a solvent exit does not automatically mean the firm will be liquidated, because that outcome depends on the circumstances. [#TGT:401295982d2ab654] If the firm is a building society, it should connect its deposit transfer/repayment plan to the fact that completing that step will mean it no longer meets the principal purpose test, and it should also consider what steps are needed for dissolution under the Building Societies Act 1986. [#TGT:401295982d2ab654]", "source_text": "A solvent exit means the process through which a firm ceases its PRA-regulated activities while remaining solvent. 2 The firm should transfer 3 or repay (or both) all deposits as part of its solvent exit. 4 In the firm’s solvent exit planning, it should build in sufficient time and resources to support the firm in meeting liabilities when they fall due and in transferring and/or repaying all deposits. At a point after this, a solvent exit will end with the removal of deposit-taking activity from the firm’s Part 4A permission, or with the cancellation of the firm’s Part 4A permission (hereinafter referred to as the removal of the firm’s Part 4A PRA permission). 5", "target_text": "4. A solvent exit does not necessarily result in the liquidation of the firm, as it depends on the circumstances. If the firm is a building society, the transfer and/or repayment of all deposits will mean it ceases to meet the principal purpose test. Therefore, a building society should also take into account steps which are necessary for it to be dissolved under the Building Societies Act 1986.", "source_passage_id": "a9dcecc8a5a3b33a", "target_passage_id": "401295982d2ab654", "method": "DPEL", "persona": "basic"}
{"item_id": "f14abbf591ee625b", "question": "If a firm is working out its expense provision at the valuation date, what does it need to do with its real expenses from the last 12 months and inflation assumptions, while also making sure the provision is big enough for the scenario where it stops taking new business 12 months after the valuation date (net of tax)?", "gold_answer": "The firm needs to build an expense provision that is anchored in its recent actual costs and prudent inflation expectations, but that also meets a minimum sufficiency test tied to a specific “stop new business” scenario. [#TGT:d5f33a809f90d2bc] [#SRC:76b4e3f63e49250f] First, the provision for expenses (whether implicit or explicit) must not fall below the amount that, on prudent assumptions, would be needed to cover the total net cost of fulfilling contracts, after taking taxation effects into account, if the firm were to cease transacting new business twelve months after the valuation date. [#SRC:76b4e3f63e49250f] Second, when setting that provision, the firm must look back at what it actually spent in the twelve months before the valuation date, and it must also consider how inflation will affect future expenses. [#TGT:d5f33a809f90d2bc] The inflation element must be based on prudent assumptions about future increases in prices and earnings, so the provision reflects expected growth in expenses rather than only past spending. [#TGT:d5f33a809f90d2bc] Putting these together, the firm should ensure the provision is informed by the last year’s actual expenses and prudent inflation projections, while still being at least large enough to cover the net-of-tax contract-fulfilment costs under the twelve-month cessation scenario. [#SRC:76b4e3f63e49250f] [#TGT:d5f33a809f90d2bc]", "source_text": "In accordance with 13.2 , a firm’s provision for expenses, whether implicit or explicit, must not be less than the amount required, on prudent assumptions, to meet the total net cost (after taking account of the effect of taxation) that would be likely to be incurred in fulfilling contracts if the firm were to cease to transact new business twelve months after the valuation date .", "target_text": "The provision mentioned in 13.1 must have regard to the firm's actual expenses in the last twelve months before the valuation date and the effects of inflation on future expenses on prudent assumptions as to the future rates of increase in prices and earnings.", "source_passage_id": "76b4e3f63e49250f", "target_passage_id": "d5f33a809f90d2bc", "method": "DPEL", "persona": "basic"}
{"item_id": "8a958b85ce88acbd", "question": "What does it mean for a firm to “prepare for resolution” under Fundamental Rule 8, and how does that connect to the PRA and the Bank as resolution authority talking to the home state supervisor and/or home resolution authority and then asking the firm for more information?", "gold_answer": "Preparing for resolution under Fundamental Rule 8 means the firm must get itself ready so that, if resolution is needed, it can be handled in an orderly way and with as little disruption as possible to critical services. [#TGT:ba7a108ec58f63f0] The resolution planning information the firm provides should therefore describe preparations that support that outcome, because the purpose of the preparation is to enable an orderly resolution with minimal disruption of critical services. [#TGT:ba7a108ec58f63f0] The PRA and the Bank as resolution authority play an active role in reviewing and testing whether the firm’s information is sufficient: they will discuss the firm’s resolution preparations with one or both of the home state supervisor and the home resolution authority. [#SRC:b277461e673dbd9a] After those discussions, they will consider whether they need any additional information from the firm. [#SRC:b277461e673dbd9a] So, the firm should be ready not only to provide initial resolution planning information, but also to respond if the PRA and the Bank as resolution authority decide—based on engagement with the relevant home authorities—that more information is required to assess the firm’s readiness for orderly resolution and continuity of critical services. [#SRC:b277461e673dbd9a] [#TGT:ba7a108ec58f63f0]", "source_text": "resolution planning, including information regarding the group’s preparations for resolution consistent with Fundamental Rule 8 (the PRA, and the Bank as resolution authority, will discuss with one or both among the home state supervisor and home resolution authority, and then consider if any additional information is required from the firm).", "target_text": "Fundamental Rule 8: A firm must prepare for resolution so, if the need arises, it can be resolved in an orderly manner with a minimum disruption of critical services.", "source_passage_id": "b277461e673dbd9a", "target_passage_id": "ba7a108ec58f63f0", "method": "DPEL", "persona": "basic"}
{"item_id": "5bd97538bc2ccbf9", "question": "In calibrating the PRA buffer for a new bank, when does the PRA’s time-limited approach cease to apply and what supervisory-judgement basis allows the PRA to move earlier to an established-bank stress-testing calibration, including the type of circumstances that could justify diverging from the stated approach?", "gold_answer": "The PRA’s time-limited approach for setting the PRA buffer for new banks ends once either of the relevant conditions referenced in the prior material (paragraph 4.8) no longer applies; at that point, the bank’s PRA buffer is calibrated using the bank’s stress testing assessments in the same manner as for established banks. [#SRC:786185f23d84f194] Separately, the PRA may bring forward that transition: the text indicates that an earlier move to the established-bank, stress-testing-based calibration can be introduced where the PRA identifies heightened risks to its objectives. [#SRC:786185f23d84f194] In addition, when exercising supervisory judgement, the PRA may—only in exceptional circumstances—diverge from the stated approach to calculating the PRA buffer for new and growing banks, including where the stated approach would fail to avoid a disproportionate level of capital relative to financial stability risks. [#TGT:7cb7aa7ed1a3d55a] That divergence power explicitly includes cases where the PRA identifies heightened risks to its objectives that justify an earlier transition to the PRA buffer approach used for established banks. [#TGT:7cb7aa7ed1a3d55a] Accordingly, the default trigger for ending the time-limited approach is the cessation of the referenced conditions, but supervisory judgement can justify an earlier shift (or other divergence) in exceptional circumstances, including heightened-risks scenarios and outcomes that would otherwise be disproportionate to financial stability risks. [#SRC:786185f23d84f194] [#TGT:7cb7aa7ed1a3d55a]", "source_text": "The PRA’s approach for setting the PRA buffer is designed to support new banks in their early years of operation, and as such is time-limited. Once either of the conditions set out above (paragraph 4.8 ) no longer apply, the bank’s PRA buffer will be calibrated using the bank’s stress testing assessments, in line with established banks. However, as stated in paragraph 4.12 , such an approach could be introduced earlier where the PRA identifies heightened risks to its objectives.", "target_text": "When exercising its supervisory judgement, the PRA may, in exceptional circumstances, diverge from the stated approach to calculating the PRA buffer for new and growing banks, for instance where the stated approach does not achieve the intended outcome of avoiding a disproportionate level of capital relative to financial stability risks. Such divergence could also include instances where the PRA identifies heightened risks to its objectives which justify an earlier transition to the PRA buffer in line with established banks.", "source_passage_id": "786185f23d84f194", "target_passage_id": "7cb7aa7ed1a3d55a", "method": "DPEL", "persona": "professional"}
{"item_id": "72c961c5198333b5", "question": "If a firm is a ‘UK trading bank’ (as defined in the text) and the PRA’s booking expectations apply to it, who should be put in charge of overseeing booking arrangements, what paperwork should show that, and when could someone in the parent or another group company need SMF7 approval?", "gold_answer": "If the firm is a ‘UK trading bank’—meaning it is a PRA-authorised bank or designated investment firm that is UK-headquartered or part of a UK-based group and it carries on investment banking or sales and trading activities in both the UK and overseas—then it is within the scope of the PRA’s booking-arrangements expectations identified in the supervisory statement (including the specified paragraphs and the Annex on Context and definitions). [#SRC:a3ab5e4ef313b90a] Where those expectations apply, the PRA expects the firm to give an SMF responsibility for overseeing the firm’s booking arrangements. [#TGT:a696590f07b39032] The firm should also record that responsibility in the relevant person’s Statement of Responsibilities so the oversight role is formally documented. [#TGT:a696590f07b39032] Separately, if people in the parent or other group entities have significant influence over how one or more aspects of the firm’s UK regulated activities are managed or conducted, it may be appropriate for those individuals to be approved as a Group Entity Senior Manager (SMF7). [#TGT:a696590f07b39032] The supervisory statement also signals that it clarifies where booking expectations apply to international banks only versus both international banks and UK trading banks, and it points to a terminology summary for scope. [#SRC:a3ab5e4ef313b90a]", "source_text": "In addition, the sections on the PRA’s expectations of booking arrangements [ Chapter 4 ] also apply to all PRA-authorised banks and designated investment firms that are headquartered in the UK or are part of a group based in the UK, and have investment banking or sales and trading activities in both the UK and overseas. In this SS, these firms are denoted ‘UK trading banks’. These sections comprise paragraphs 4.1(d) , 4.20 , 4.23 , 4.25Y, 4.25AE , 5.14-5.16 and the Annex on Context and definitions. We make clear in the relevant sections where the expectations apply to international banks alone, and where they apply to international banks and UK trading banks. See paragraph 4.24B for a summary of the terminology used to describe the scope of application for the booking expectations.", "target_text": "Where applicable, the PRA expects firms to allocate the responsibility for overseeing the firm’s booking arrangements to an SMF, and record this appropriately in their Statement of Responsibilities. Where individuals in the parent or in group entities exercise significant influence over the management or conduct of one or more aspects of the firm’s UK regulated activities, it may be appropriate for them to be approved as a Group Entity Senior Manager (SMF7). However, firms have applied for individuals performing a range of functions to be approved as SMF7. Examples include:", "source_passage_id": "a3ab5e4ef313b90a", "target_passage_id": "a696590f07b39032", "method": "DPEL", "persona": "basic"}
{"item_id": "0d3bb87893f163e4", "question": "If a UK subsidiary is part of a group based outside the UK, what does it need to do about fire drill exercises and UK playbooks when getting ready to send its recovery plan to the PRA?", "gold_answer": "The UK subsidiary should link its UK recovery planning work on playbooks with the PRA’s expectations for fire drill exercises on the recovery plan. [#SRC:f4ab9388eafb627e] Specifically, it should run a fire drill exercise that is a ‘live’ simulation where the firm acts out key parts of its response to a designed scenario, because this is used to test how effective the recovery plan is in a live setting. [#TGT:2c1d7b1bf1be0e5f] The PRA expects at least one such fire drill to be completed before each time the recovery plan is submitted to the PRA, and there must be at least one fire drill every three years even if submissions are less frequent. [#TGT:2c1d7b1bf1be0e5f] Alongside that fire-drill planning, the subsidiary should consider the guidance on fire drills and playbooks referenced for UK subsidiaries of non-UK groups, and if the PRA explicitly asks for more detailed UK playbook work as part of UK recovery planning, the firm should contact its supervisor to discuss whether the request applies. [#SRC:f4ab9388eafb627e] Because the PRA sets recovery plan submission frequency firm-by-firm (often annually for larger firms), the firm should align its fire drill timing to that PRA-determined cycle. [#TGT:2c1d7b1bf1be0e5f]", "source_text": "(vii) UK subsidiaries of groups based outside of the UK should also consider the guidance on fire drills and playbooks set out in Chapter 2 (vi) and (vii) . In some cases, the PRA may explicitly ask firms to undertake more detailed work on UK playbooks as part of their UK recovery planning work. Firms should contact their supervisor to discuss whether this applies.", "target_text": "Fire drill exercises are ‘live’ simulation type exercises where firms act out key parts of a response to a designed scenario. This is a useful way to test the effectiveness of the recovery plan in a ‘live’ situation. The PRA expects each firm to carry out at least one fire drill exercise on its recovery plan prior to each submission of the recovery plan to the PRA, subject to a minimum of one fire drill taking place every three years. The PRA determines the frequency with which firms should submit their recovery plan on a firm-by-firm basis, with larger firms tending to submit their plans on an annual cycle.", "source_passage_id": "f4ab9388eafb627e", "target_passage_id": "2c1d7b1bf1be0e5f", "method": "DPEL", "persona": "basic"}
{"item_id": "dc964006e4297440", "question": "If a firm is listing risks for its SCR work, what should it write down about risks that are not (or not fully) in the SCR calculation, and how does that fit with the rule that calibration must take in all quantifiable risks (including the named underwriting, market, credit, and operational risks)?", "gold_answer": "The firm should document two things side by side: the risks that are part of the SCR calculation and the risks that are missing from it or only partly captured, and it should do this in a way that supports a calibration designed to include all quantifiable risks the firm is exposed to. [#SRC:c2d9c82eaebd8586] [#TGT:f261181a95a3ca51] Specifically, the firm’s write-up must cover the risks that are included in the SCR calculation and also call out the risks that are not, or not fully, included in that calculation. [#SRC:c2d9c82eaebd8586] Separately, the calibration requirement sets the expectation that all quantifiable risks to which the firm is exposed are taken into account, and it gives a minimum set that must be included: non-life underwriting risk, life underwriting risk, health underwriting risk, market risk, credit risk, and operational risk. [#TGT:f261181a95a3ca51] Putting these together, the firm should not assume the SCR calculation list is complete; instead, it should use the “not, or not fully, included” section to identify any quantifiable exposures that still need to be considered to meet the calibration expectation, even if they are not fully reflected in the SCR calculation. [#SRC:c2d9c82eaebd8586] [#TGT:f261181a95a3ca51]", "source_text": "(b) cover the risks to be included in the calculation of the SCR as set out in Solvency Capital Requirement - General Provisions 3.3(1) , as well as the risks which are not, or not fully, included in the calculation thereof; and", "target_text": "(1) must be calibrated to ensure that all quantifiable risks to which the firm is exposed are taken into account, including at least the non-life underwriting risk , life underwriting risk , health underwriting risk , market risk , credit risk , and operational risk ;", "source_passage_id": "c2d9c82eaebd8586", "target_passage_id": "f261181a95a3ca51", "method": "DPEL", "persona": "basic"}
{"item_id": "0b4cdf1973b02601", "question": "If an insurer is thinking about paying a dividend, what does the PRA expect it to be able to show, and does the same kind of check apply if the payment is instead a return of premiums to members of a mutual or a loan to a parent/holding company?", "gold_answer": "The insurer should be able to show that any planned dividend payment makes sense when compared to (1) how the business has performed and is expected to perform and (2) the insurer’s capital position now and in the future, and it should do this while taking its documented risk appetite into account. [#SRC:7acd5cecad84d469] This is not limited to dividends in a narrow sense: the same assessment is meant to cover distributions to any capital providers, which can include returning premiums to the members of a mutual and making a loan to a parent or holding company. [#TGT:6edb0118e73ad6e9] In practice, the insurer should prepare an explanation (and supporting analysis) that links the planned payment or transfer to actual and projected business performance and to current and future capital strength, and shows how those factors were considered against the risk appetite that has been documented. [#SRC:7acd5cecad84d469] If the transaction is a return of premiums or a loan to a parent/holding company, it should still be treated as a distribution to a capital provider and assessed using the same appropriateness logic. [#TGT:6edb0118e73ad6e9]", "source_text": "When assessing potential dividend payments, 10 the PRA expects insurers to be able to demonstrate that any planned dividend payments are appropriate in relation to actual and projected business performance, as well as the current and future capital position of the insurer, taking account of its documented risk appetite.", "target_text": "10. This would include here the assessment made for distributions to any capital providers, including for a return of premiums to the members of a mutual, or for a loan to a parent or holding company.", "source_passage_id": "7acd5cecad84d469", "target_passage_id": "6edb0118e73ad6e9", "method": "DPEL", "persona": "basic"}
{"item_id": "dca990d966d86829", "question": "If a firm is using the IFRS 9 transitional arrangements, what does the PRA look at when deciding whether the firm needs a bigger capital buffer, and how does that connect to when IFRS 9 started applying and what older standard it replaced?", "gold_answer": "Where a firm is using IFRS 9 transitional arrangements, the PRA’s decision on whether the firm should hold a larger buffer or strengthen its capital position is based on a combination of prudential factors and a time-limited transitional assessment. [#SRC:ca2603599644f9a7] The PRA expects firms to increase buffers or strengthen capital where necessary in light of factors including the firm’s leverage ratio, Tier 1 and total capital ratios, risks associated with double leverage, and whether potentially significant risks are not fully captured by the stress test. [#SRC:ca2603599644f9a7] In addition, up to the end of 2023, the PRA will assess firms’ capital positions under transitional arrangements for IFRS 9 when firms are using those arrangements. [#SRC:ca2603599644f9a7] This transitional focus is tied to IFRS 9’s role as the accounting standard for financial instruments: IFRS 9 set new accounting rules for financial instruments and replaced IAS 39, and it is effective for annual periods beginning on or after 1 January 2018 (after EU endorsement). [#TGT:9d3a529207cb52b1] So, for firms using the transition, the PRA’s capital-buffer judgement can reflect both the usual capital/risk indicators and the specific IFRS 9 transitional assessment through end-2023, in the context of IFRS 9’s post-2018 replacement of IAS 39. [#SRC:ca2603599644f9a7] [#TGT:9d3a529207cb52b1]", "source_text": "The PRA expects firms to hold a larger buffer or strengthen their capital position where necessary based on other factors. These include, but are not limited to: the firm’s leverage ratio; Tier 1 and total capital ratios; risks associated with double leverage; and the extent to which potentially significant risks are not captured fully as part of the stress test. Until the end of 2023, the PRA will also assess firms’ capital positions under transitional arrangements for International Financial Reporting Standards (IFRS) 9, 53 where firms are using these arrangements.", "target_text": "53. IFRS 9 was issued in July 2014 and sets out new rules for accounting for financial instruments, replacing the rules in International Accounting Standard (IAS) 39. Following endorsement for use in the EU, IFRS 9 is effective for annual periods beginning on or after 1 January 2018. The PRA’s communications to firms on IFRS 9 are available on the Bank’s website at https://www.bankofengland.co.uk/prudential-regulation/letter/2017/transition-disclosures-for-ifrs9-financial-instruments .", "source_passage_id": "ca2603599644f9a7", "target_passage_id": "9d3a529207cb52b1", "method": "DPEL", "persona": "basic"}
{"item_id": "9e36a373160cab58", "question": "When an institution is calculating the own funds requirement for its pre-funded contributions to the default fund of a QCCP using the approach in Article 308, how should it determine the exposure value of that pre-funded contribution, including any reduction for amounts already applied by the QCCP after a clearing member default?", "gold_answer": "In calculating the own funds requirement for its pre-funded contributions to the default fund of a QCCP, the institution must apply the approach specified in Article 308, and that calculation must be based on an exposure value determined under the rule for DFi. [#SRC:b21669d5cc795148] The exposure value for the institution’s pre-funded contribution to the QCCP default fund (DFi) is the amount the institution has paid in, or alternatively the market value of assets it has delivered, and this starting amount must be reduced by any portion of that contribution that the QCCP has already used to absorb losses that arose after the default of one or more of the QCCP’s clearing members. [#TGT:5b56ca243fc390af] Accordingly, the institution should (i) identify whether its contribution was made as cash paid in or as assets delivered and, if assets were delivered, use their market value, and (ii) subtract any amount of that same contribution that has already been applied by the QCCP to cover losses in the specified default scenario. [#TGT:5b56ca243fc390af] This reduced DFi exposure value is the relevant measure to feed into the Article 308 approach when calculating the own funds requirement for the institution’s pre-funded default fund contribution. [#SRC:b21669d5cc795148]", "source_text": "(a) it shall calculate the own funds requirement for its pre-funded contributions to the default fund of a QCCP in accordance with the approach set out in Article 308 ;", "target_text": "The exposure value for an institution's pre-funded contribution to the default fund of a QCCP (DFi) shall be the amount paid in or the market value of the assets delivered by that institution reduced by any amount of that contribution that the QCCP has already used to absorb its losses following the default of one or more of its clearing members .", "source_passage_id": "b21669d5cc795148", "target_passage_id": "5b56ca243fc390af", "method": "DPEL", "persona": "professional"}
{"item_id": "7e8102fccdc3b2c1", "question": "When explaining why SEC-SA and SEC-IRBA may not fully capture non-credit risks in securitisation, how should a firm describe the role of the framework’s “non-neutrality,” including what it means in RWA terms and which pre-defined inputs and mechanisms drive its level?", "gold_answer": "A firm should explain that SEC-SA and SEC-IRBA are designed to recognise only a defined set of items in calculating capital requirements, with the emphasis mainly on credit risk, so they can miss the presence of non-credit risks associated with securitisation. [#SRC:b660733416fb3965] It should then link this limitation to the framework’s “non-neutrality,” noting that some additional non-credit risks arising from securitisation are, to a degree, reflected through that non-neutrality, but the extent of the effect is determined by pre-defined inputs such as STS status. [#SRC:b660733416fb3965] In RWA terms, “non-neutrality” should be described as the typical outcome that the total RWAs for the securitisation tranches exceed the RWAs that would have been calculated for the same underlying portfolio if it had not been securitised. [#TGT:dbb9be39416dec17] The firm should also identify the specific mechanisms by which SEC-SA and SEC-IRBA introduce this non-neutrality: a risk weight floor that differs by STS classification (10% for STS positions and 15% for non-STS positions) and the supervisory “p” factor. [#TGT:dbb9be39416dec17] Together, these points connect the methods’ credit-risk focus with the way non-neutrality can partially reflect other securitisation-related risks, while remaining driven by preset parameters. [#SRC:b660733416fb3965]", "source_text": "The SEC-SA and SEC-IRBA methods can only recognise a defined number of items in their calculation of capital requirements, primarily focused on credit risk. These methods may fail to recognise the presence of non-credit risks. To an extent some additional non-credit risks which can arise from securitisation are reflected in the ‘non-neutrality’ of the securitisation capital framework. 1 However the level of non-neutrality is driven by pre-defined inputs (eg STS status).", "target_text": "1. ‘Non-neutrality’ of the framework here means that typically the total RWAs calculated for the tranches of a securitisation will be higher than the RWAs calculated for the underlying portfolio had it not been securitised. In the SEC-SA and SEC-IRBA, this non-neutrality is introduced primarily through the application of a risk weight floor (10% for STS positions and 15% for non-STS positions) and the supervisory ‘p’ factor.", "source_passage_id": "b660733416fb3965", "target_passage_id": "dbb9be39416dec17", "method": "DPEL", "persona": "professional"}
{"item_id": "debe51e570b9b994", "question": "If a society has already passed the Transfer Resolutions, what must it do before the transfer can take effect, and what should the directors do (with external auditors or other advisers) to make sure the society can meet the PRA’s expectations when applying for approval of the Transfer Statement and later seeking confirmation?", "gold_answer": "Once the Transfer Resolutions have been passed, the society must apply to the PRA for confirmation of the transfer in the way the PRA directs, and the transfer cannot take effect unless and until the PRA confirms it. [#TGT:22dea1e31d8e0cd5] To support that process, the directors should first check—together with the society’s external auditors or other advisers—that the society’s systems can produce the required information, because the PRA will ask for an assurance about that systems capability when the society applies for approval of the Transfer Statement. [#SRC:6f71cdabf69e733c] The directors should also plan for the confirmation stage as a separate PRA decision point, because the PRA considers (among its confirmation criteria) whether any relevant requirement of the 1986 Act or the Rules was not met, which means gaps in process or information readiness can matter at confirmation even if the society is already moving through the application steps. [#SRC:6f71cdabf69e733c] [#TGT:22dea1e31d8e0cd5] Practically, this means sequencing internal assurance work so it is available for the Transfer Statement approval application while also ensuring the overall transfer process is compliant before the PRA considers confirmation and any representations. [#SRC:6f71cdabf69e733c] [#TGT:22dea1e31d8e0cd5]", "source_text": "The directors of a society contemplating a transfer must satisfy themselves, in consultation with their external auditors, or other advisers, that the society’s systems are capable of delivering the information described above. The PRA will require an assurance on this point when the society applies for approval of the Transfer Statement. One of the criteria which the PRA has to consider at the confirmation stage is whether some relevant requirement of the 1986 Act or the Rules was not fulfilled (see section ‘ Confirmation ’).", "target_text": "No transfer can take effect until it has been confirmed by the PRA. This section first describes the form of application and public notice required. It then explains the PRA view of how the statutory Confirmation Criteria should be interpreted. Finally, it gives guidance on the procedure customarily followed by the PRA when considering confirmation applications and hearing representations. Sections 97(4)(d) and 98(2) of, together with Part II of Schedule 17 to the 1986 Act, provide that when the necessary Transfer Resolutions have been passed the society must apply to the PRA for confirmation of the transfer in such manner as the PRA may direct.", "source_passage_id": "6f71cdabf69e733c", "target_passage_id": "22dea1e31d8e0cd5", "method": "DPEL", "persona": "basic"}
{"item_id": "238498945ac2d31d", "question": "If you normally have to work out the long-term insurance liability using a forward-looking (prospective) calculation for each contract, when are you allowed to use a backward-looking (retrospective) calculation instead, and what do you need to show?", "gold_answer": "You generally must determine the amount of the long-term insurance liability for each contract using a prospective calculation, so the standard method is forward-looking and applied at the individual contract level. [#SRC:72c3af495575a5fb] You may switch to a retrospective calculation only in specific situations that relate to whether a prospective method can be used and whether the retrospective result is at least as conservative as a prudent prospective result. [#TGT:30f622a929df3844] First, a retrospective calculation is allowed where a prospective method cannot be applied to a particular type of contract or benefit; this is an exception that depends on the nature of the contract or benefit, even though the liability is still being determined for each contract. [#TGT:30f622a929df3844] [#SRC:72c3af495575a5fb] Second, even if a prospective method could be applied, you may use a retrospective calculation if you can demonstrate that the liabilities it produces would be no lower than what would be required by a prudent prospective calculation; the key requirement is the demonstration of a non-lower outcome against that prudent prospective benchmark. [#TGT:30f622a929df3844] Outside these conditions, the prospective calculation remains the required approach for determining the long-term insurance liability for each contract. [#SRC:72c3af495575a5fb] [#TGT:30f622a929df3844]", "source_text": "Subject to 7.2 , 7.3 and 7.4 , the amount of the long-term insurance liability must be determined for each contract by a prospective calculation.", "target_text": "A retrospective calculation may only be applied to determine the liabilities where a prospective method cannot be applied to a particular type of contract or benefit, or where it can be demonstrated that the resulting amount of liabilities would be no lower than would be required by a prudent prospective calculation.", "source_passage_id": "72c3af495575a5fb", "target_passage_id": "30f622a929df3844", "method": "DPEL", "persona": "basic"}
{"item_id": "0431fe19946ef391", "question": "When the PRA is deciding whether a firm should hold a larger buffer or otherwise strengthen its capital position, how should the PRA’s assessment of capital under IFRS 9 transitional arrangements (including the time limit for that assessment) be understood in light of when IFRS 9 became effective and what it replaced?", "gold_answer": "In deciding whether a firm should hold a larger buffer or strengthen its capital position, the PRA’s assessment can include both general capital/risk factors and, for a limited period, an additional lens tied to IFRS 9 transitional arrangements. [#SRC:ca2603599644f9a7] Specifically, the PRA expects firms to increase buffers or strengthen capital where needed based on factors such as the firm’s leverage ratio, Tier 1 and total capital ratios, risks from double leverage, and the extent to which potentially significant risks are not fully captured in the stress test. [#SRC:ca2603599644f9a7] Alongside those factors, until the end of 2023 the PRA will also assess firms’ capital positions under transitional arrangements for IFRS 9 where firms are using those arrangements. [#SRC:ca2603599644f9a7] This transitional-assessment element relates to IFRS 9 as the accounting framework for financial instruments: IFRS 9 introduced new accounting rules for financial instruments and replaced the prior rules in IAS 39, and it became effective for annual periods beginning on or after 1 January 2018 (following EU endorsement). [#TGT:9d3a529207cb52b1] Taken together, the PRA’s capital-buffer expectations may be informed by both the firm’s prudential metrics and risk capture, and—where applicable—by how the firm’s capital position is assessed under the IFRS 9 transitional arrangements through end-2023, in the context of IFRS 9’s post-2018 effective regime replacing IAS 39. [#SRC:ca2603599644f9a7] [#TGT:9d3a529207cb52b1]", "source_text": "The PRA expects firms to hold a larger buffer or strengthen their capital position where necessary based on other factors. These include, but are not limited to: the firm’s leverage ratio; Tier 1 and total capital ratios; risks associated with double leverage; and the extent to which potentially significant risks are not captured fully as part of the stress test. Until the end of 2023, the PRA will also assess firms’ capital positions under transitional arrangements for International Financial Reporting Standards (IFRS) 9, 53 where firms are using these arrangements.", "target_text": "53. IFRS 9 was issued in July 2014 and sets out new rules for accounting for financial instruments, replacing the rules in International Accounting Standard (IAS) 39. Following endorsement for use in the EU, IFRS 9 is effective for annual periods beginning on or after 1 January 2018. The PRA’s communications to firms on IFRS 9 are available on the Bank’s website at https://www.bankofengland.co.uk/prudential-regulation/letter/2017/transition-disclosures-for-ifrs9-financial-instruments .", "source_passage_id": "ca2603599644f9a7", "target_passage_id": "9d3a529207cb52b1", "method": "DPEL", "persona": "professional"}
{"item_id": "612e14e64c742ecb", "question": "If the firm is working out its exposure to a type of asset by adjusting values under 19 to 23, what extra amount has to be added for assets of that type that were transferred as initial margin, and what starting value should the firm use for that asset type (especially if there is no specific valuation rule for it)?", "gold_answer": "To calculate exposure for each asset description, the firm must first assign a value to that asset description using the amount determined under this Part’s valuation rules, or—if there is no valuation provision for that asset description—using an amount that would reasonably be paid for an immediate assignment or transfer. [#TGT:596695fe437c2dff] The firm then determines how much it is exposed to that asset description by adjusting the ascribed value in line with 19 to 23. [#TGT:596695fe437c2dff] When applying the valuation steps under 18 to 20 within that adjustment process, the firm must increase the value ascribed for assets of the relevant description by an amount representing the value of any assets of that description that the firm has transferred by way of initial margin. [#SRC:b5aade12a934b433] In practical terms, the initial “starting value” comes from the Part’s valuation approach (or a reasonable immediate-transfer price where no approach exists), and the exposure figure must reflect an added amount for initial-margin transfers of the same asset description when the 18 to 20 valuation is used as part of the 19 to 23 adjustments. [#SRC:b5aade12a934b433] [#TGT:596695fe437c2dff]", "source_text": "The value ascribed under 18 to 20 in respect of assets of each description must be increased by an amount representing the value of any assets of that description which have been transferred by the firm by way of initial margin .", "target_text": "A value must be ascribed to assets of each description which must be an amount determined in accordance with this Part or, where the assets are of a description for the valuation of which no provision is made in those rules, an amount which would reasonably be paid by way of consideration for an immediate assignment or transfer of such assets. The amount by which the firm is exposed to assets of each description must be determined by adjusting the value of the assets in accordance with 19 to 23 .", "source_passage_id": "b5aade12a934b433", "target_passage_id": "596695fe437c2dff", "method": "DPEL", "persona": "basic"}
{"item_id": "610268530bbbb922", "question": "When applying the prohibition on post-recognition own-credit adjustments for financial liabilities valued under UK-adopted international accounting standards, how should a firm treat valuation adjustments related to changes in its own credit standing, and how does this align with the rule for an insurance or reinsurance undertaking under Valuation 10.1?", "gold_answer": "A firm should treat changes in its own credit standing as irrelevant for any valuation adjustment after the liability has been initially recognised, and this approach aligns with the specific rule that an insurance or reinsurance undertaking must not apply a valuation adjustment for changes in its own credit standing. [#TGT:f26605efb3832de6] In scope, the firm’s obligation applies to financial liabilities that are valued under UK-adopted international accounting standards, and the valuation at the point of initial recognition must follow the referenced “5” requirement. [#TGT:f26605efb3832de6] After that initial recognition point, the firm is prohibited from making later valuation changes that reflect its own credit standing moving up or down. [#TGT:f26605efb3832de6] This is consistent with the Valuation 10.1 statement that there is to be no valuation adjustment that takes account of a change in the own credit standing of the insurance or reinsurance undertaking. [#SRC:d6c3553c96db7f71] Read together, the combined effect is that, whether framed as a general firm requirement for financial liabilities post-initial recognition or as the Valuation 10.1 rule for an insurance or reinsurance undertaking, own-credit movements are not a permitted driver of valuation adjustments. [#TGT:f26605efb3832de6] [#SRC:d6c3553c96db7f71]", "source_text": "Subsequently, the second sentence of Valuation 10.1 ; there shall be no valuation adjustment to take account of the change in own credit standing of the insurance or reinsurance undertaking.", "target_text": "A firm must value financial liabilities, as referred to in UK-adopted international accounting standards , in accordance with 5 upon initial recognition. A firm must not make any subsequent adjustment to take account of the change in own credit standing of the firm after initial recognition.", "source_passage_id": "d6c3553c96db7f71", "target_passage_id": "f26605efb3832de6", "method": "DPEL", "persona": "professional"}
{"item_id": "a5796a50352fc9c5", "question": "If a firm wants to back TPs with an intragroup loan to another group company, what does it need to show about how the asset is invested, and why does the PRA say it is hard to prove this kind of loan is suitable?", "gold_answer": "To use an intragroup loan as an asset backing TPs, the firm needs to be able to show that the asset is invested in a way that matches the nature and duration of the firm’s insurance and reinsurance liabilities and that it is in the best interests of all policyholders, while also considering any disclosed policy objectives. [#SRC:afb7633ef682266c] The PRA highlights that intragroup loans (and similar participations or arrangements) can be problematic under this standard because they may benefit shareholders without necessarily benefiting policyholders. [#TGT:19e81bc332eae024] The PRA also notes a specific risk: the issuer of the loan may be less willing or able to enforce repayment, particularly for upstream loans, which can undermine the case that the arrangement protects policyholders’ interests. [#TGT:19e81bc332eae024] Because of these concerns, the PRA expects there is a high hurdle for firms to demonstrate that intragroup loans and participations are in policyholders’ best interests, and therefore a high hurdle to demonstrate they are appropriate for covering TPs. [#TGT:19e81bc332eae024] This means the firm’s explanation must satisfy both the general investment standard for TP-backing assets and the PRA’s heightened scrutiny for intragroup transactions. [#SRC:afb7633ef682266c] [#TGT:19e81bc332eae024]", "source_text": "In respect of assets backing TPs, the PPP requires that these must be invested ‘in a manner appropriate to the nature and duration of the firm’s insurance and reinsurance liabilities and in the best interests of all policyholders, taking into account any disclosed policy objectives’. 39", "target_text": "The requirement for assets backing TPs to be invested in policyholders’ best interests has particular implications for certain intragroup transactions such as intragroup loans and participations or arrangements to that effect. Investments in, or loans to, other group companies may be in the interests of shareholders but they may not necessarily be in the best interests of policyholders. For example, the issuers of loans may be less willing or able to enforce repayment, particularly where loans are upstream. The PRA expects that it would be a high hurdle for firms to demonstrate that intragroup loans and participations are in the best interests of policyholders and, as such, a high hurdle to demonstrate that they are appropriate for covering TPs.", "source_passage_id": "afb7633ef682266c", "target_passage_id": "19e81bc332eae024", "method": "DPEL", "persona": "basic"}
{"item_id": "4c9b2d55ceb1dd0a", "question": "If the firm is a UK ISPV, whose signatures are needed on the 5.4 record every time it is updated?", "gold_answer": "If the firm is a UK ISPV, the 5.4 signing rule still applies, but the role named in that rule is adjusted: any mention of a key function holder is read as meaning a PRA senior management function holder. [#SRC:72db45975ca3958c] With that adjustment, the 5.4 record and each updated version must carry two signatures: one from the PRA senior management function holder (in place of the key function holder) and one from an appropriate representative of the firm. [#TGT:8e03ecfaf3ea1715] Practically, this requires the firm to obtain both signatures not only when the record is first prepared but also whenever the record is revised, because the requirement explicitly covers “each updated version.” [#TGT:8e03ecfaf3ea1715] The UK ISPV-specific reading is what determines which individual satisfies the “key function holder” signatory slot, so the firm should route the record to the relevant PRA senior management function holder for signature rather than treating the key function holder as a separate category for UK ISPV purposes. [#SRC:72db45975ca3958c]", "source_text": "The requirements in 5.4 and 5.6 apply to a firm that is a UK ISPV as if any reference to a key function holder were a reference to a PRA senior management function holder .", "target_text": "The record in 5.4 , and each updated version, must be signed by the key function holder and an appropriate representative of the firm .", "source_passage_id": "72db45975ca3958c", "target_passage_id": "8e03ecfaf3ea1715", "method": "DPEL", "persona": "basic"}
{"item_id": "8636f4a0fffe9f03", "question": "If someone is in scope because they perform a PRA senior management function or an FCA designated senior management function (with the “subject to 3.6(1)” note), can the firm give them a prescribed responsibility if they also perform an FCA other overall responsibility senior management function?", "gold_answer": "No. If the person performs an FCA other overall responsibility senior management function, the firm is not allowed to allocate a prescribed responsibility to them. [#TGT:afb87828d72640b4] The set of people you may be looking at for this decision includes those who perform a PRA senior management function and those who perform an FCA designated senior management function, and the FCA designated category is explicitly stated to operate with a “subject to 3.6(1)” qualifier. [#SRC:3a4602dcc6094903] So the firm should (1) confirm the person is being considered in the relevant senior management function population (PRA senior management function or FCA designated senior management function, applying the qualifier), and then (2) check whether they perform an FCA other overall responsibility senior management function. [#SRC:3a4602dcc6094903] If they do perform that FCA other overall responsibility senior management function, the prohibition applies and the prescribed responsibility must not be allocated to them, even if they also fall within the PRA or FCA designated senior management function categories. [#TGT:afb87828d72640b4]", "source_text": "(1) performs a PRA senior management function or, subject to 3.6 (1), an FCA designated senior management function ; and", "target_text": "(1) A firm must not allocate a prescribed responsibility to a person who performs an FCA other overall responsibility senior management function .", "source_passage_id": "3a4602dcc6094903", "target_passage_id": "afb87828d72640b4", "method": "DPEL", "persona": "basic"}
{"item_id": "93a53b4077533bed", "question": "Where the PRA has consented to a transferee society proceeding by board resolution (so that it is exempt from putting Merger Resolutions and sending a Schedule 16 Statement to its members), what timetable-management steps should the societies still follow from the point their boards resolve to seek a merger, and what member notifications must be included in the Merger Document?", "gold_answer": "Even where the PRA has consented to a transferee society proceeding by board resolution—removing the need to put Merger Resolutions to members and to send a Schedule 16 Statement to its members—the merger should still be managed against a structured timetable and member-notification sequence. [#SRC:98fdd2a7fe5b0420] As a practical planning baseline, the end-to-end path from board decision through approval of the Schedule 16 Statement, a general meeting, and a confirmation hearing to the effective date is generally not expected to take less than six months, so the societies should plan on that scale when setting milestones. [#TGT:513958170c8d776a] The societies should meet with the PRA’s staff as soon as their boards have resolved to seek a merger and agree a provisional timetable, which can then be fixed by the time the Schedule 16 Statement is approved. [#TGT:513958170c8d776a] Regardless of the board-resolution consent scenario described, members must be notified (via the Merger Document) of both the provisionally set date for the confirmation hearing and the proposed completion date of the merger. [#TGT:513958170c8d776a]", "source_text": "The probable sequence of events is described more fully in section ‘ Timetable ’. The case where the PRA has consented to a transferee society proceeding by board resolution, and thereby exempting it from the requirement to put Merger Resolutions, and sending a Schedule 16 Statement, to its members, is described in paragraphs 3.149 – 3.152 .", "target_text": "The time taken to complete a merger will vary from case to case. As a general rule of thumb, it is unlikely that a merger can proceed from board decision through approval of the Schedule 16 Statement, general meeting and confirmation hearing, to the effective date, in less than six months. It is essential to the good and orderly management of a merger that the societies concerned meet with the PRA’s staff as soon as their boards have resolved to seek a merger, and agree upon a provisional timetable. This can then be fixed by the time the Schedule 16 Statement is approved. The members can then be notified, as they must be, of the date provisionally set for the confirmation hearing and of the proposed date of completion of the merger in the Merger Document.", "source_passage_id": "98fdd2a7fe5b0420", "target_passage_id": "513958170c8d776a", "method": "DPEL", "persona": "professional"}
{"item_id": "b5e2e8bd0e38dfbb", "question": "When a firm (and, where applicable, a UK holding company) reports group information that includes more than one firm using an internal model, what must be submitted to the PRA, how often, what must it contain, and under which rulebook provisions and instructions must it be submitted?", "gold_answer": "In the scenario where firms and, where applicable, UK holding companies report information on a group that includes more than one firm using an internal model, they must submit template AoC.01 to the PRA on an annual basis. [#TGT:d0d445db94d0c556] The submission must set out the analysis of change referenced in Solvency Capital Requirement – Internal Models 13A and must include both quantitative information and a supporting qualitative analysis. [#TGT:d0d445db94d0c556] AoC.01 is the PRA’s analysis of change template that firms complete with key information about movements in SCR, so the content should address the movement in SCR in the format of that template. [#SRC:282806b2f50a9291] The submission must be made in line with the instructions in section AoC.01 of Chapter 10, and it must also be submitted in accordance with Articles 19 and 35 of Chapter 2A of the Reporting Part of the PRA Rulebook. [#TGT:d0d445db94d0c556] [#SRC:282806b2f50a9291]", "source_text": "The PRA has provided an analysis of change template, named AoC.01, for firms to complete with key information regarding the movement in SCR and submit in accordance with Articles 19 and 35 of Chapter 2A of the Reporting Part of the PRA Rulebook.", "target_text": "Firms and, where applicable, UK holding companies reporting information on a group which includes more than one firm using an internal model must submit to the PRA annually template AoC.01 setting out the analysis of change referred to in Solvency Capital Requirement – Internal Models 13A , including both quantitative information and a supporting qualitative analysis, in accordance with the instructions set out in section AoC.01 of Chapter 10 .", "source_passage_id": "282806b2f50a9291", "target_passage_id": "d0d445db94d0c556", "method": "DPEL", "persona": "professional"}
{"item_id": "1911e5e0239200ee", "question": "When the PRA assesses an internal model application or a firm’s continued compliance with calibration standards 22 and internal model requirements 23 for internal model permissions, how should the firm incorporate the PRA’s requested EVT-in-stress test into its regular cycle of internal model validation (including sensitivity testing and performance monitoring) so as to support assurance that the MA in stress is not overstated?", "gold_answer": "A firm should embed the PRA-requested EVT-in-stress test within its regular internal model validation cycle so it functions as a recurring validation tool that supports the firm’s ability to demonstrate appropriate capital requirements and provides assurance that the MA in stress is not overstated. [#SRC:197d09dc7abf48b4] [#TGT:5b30ae70a80bf3bb] In practice, the EVT-in-stress exercise should be treated as part of the firm’s ongoing validation toolkit, because the PRA indicates it will ask firms to apply a test based on the EVT in stress when assessing internal model applications and continued compliance with the relevant calibration standards and internal model requirements for permissions. [#SRC:197d09dc7abf48b4] To integrate it into the required validation cycle, the firm should align the EVT-in-stress test with the cycle elements that already must exist: monitoring internal model performance and reviewing whether the model specification remains appropriate; testing model results against experience; operating an effective statistical validation process that enables the firm to demonstrate to the PRA that capital requirements are appropriate; and testing sensitivity of results to changes in key underlying assumptions (which can be informed by stressed comparisons of economic value and Effective Value). [#TGT:5b30ae70a80bf3bb] [#SRC:197d09dc7abf48b4] The firm should also ensure the data used for the EVT-in-stress work is assessed for accuracy, completeness, and appropriateness as part of the same validation cycle. [#TGT:5b30ae70a80bf3bb]", "source_text": "The PRA considers reassessment of the EVT in stress, in particular the comparison of stressed economic value and Effective Value in (iv) above, to be a helpful validation exercise that could contribute to firms meeting the internal model requirements (see Chapter 14 of the Solvency Capital Requirement – Internal Models Part of the PRA Rulebook). When assessing internal model applications and firms’ continued compliance with the calibration standards 22 and internal model requirements 23 relevant for granting internal model permissions, the PRA will ask firms to apply a test based on the EVT in stress, to assist in providing assurance that the amount of MA in stress is not overstated. Firms may wish to consider adding an EVT in stress to their regular suite of validation tools.", "target_text": "(1) A firm must have in place a regular cycle of internal model validation which includes: (a) monitoring the performance of the internal model , reviewing the ongoing appropriateness of its specification and testing its results against experience; (b) an effective statistical process for validating the internal model which enables the firm to demonstrate to the PRA that the resulting capital requirements are appropriate; (c) an analysis of the stability of the internal model and, in particular, the testing of the sensitivity of the results of the internal model to changes in key underlying assumptions; and (d) an assessment of the accuracy, completeness and appropriateness of the data used by the internal model .", "source_passage_id": "197d09dc7abf48b4", "target_passage_id": "5b30ae70a80bf3bb", "method": "DPEL", "persona": "professional"}
{"item_id": "b98bf0563dd58cbc", "question": "Where a merger’s terms provide for (i) compensation to directors or other officers for loss of office or income and (ii) bonus payments requiring members’ approval as part of the Merger Resolutions, how should the society structure member approvals, including when bonus approval must appear in the Merger Resolutions of only certain societies versus all participating societies?", "gold_answer": "Member approvals should be structured so that compensation for loss of office/income is approved through a distinct special resolution, while bonus payments are approved through the Merger Resolutions in the manner dictated by the prescribed-limit test. [#SRC:64a6d4e1a3eca833] Specifically, if the merger terms include compensation to directors or other officers for loss of office or income, those proposed payments must be put to members under a separate special resolution (i.e., not merely embedded within the general merger approval). [#SRC:64a6d4e1a3eca833] In parallel, members’ approval of bonus payments is required as part of the Merger Resolutions. [#TGT:9dfe512afd4bf0e8] The placement of that bonus approval across the participating societies depends on whether the total gross cost of the proposed bonus(es), calculated without adjusting for prospective corporation tax recovery, is within the prescribed limit. [#TGT:9dfe512afd4bf0e8] If the total gross cost is within the prescribed limit, the bonus approval need only be included in each of the Merger Resolutions of the society whose funds are to be distributed. [#TGT:9dfe512afd4bf0e8] If the total gross cost exceeds the prescribed limit, the bonus approval must be included in each of the Merger Resolutions of each participating society. [#TGT:9dfe512afd4bf0e8] This approach ensures the distinct approval route for loss-of-office compensation is maintained while bonus approvals are correctly allocated across Merger Resolutions based on the prescribed-limit threshold. [#SRC:64a6d4e1a3eca833] [#TGT:9dfe512afd4bf0e8]", "source_text": "If the terms of a merger include provision for the payment of compensation to directors or other officers for loss of office or of income, then the proposed payments must be approved by a separate special resolution. A further special resolution may also be required if there is to be a distribution to members which exceeds the limits described in paragraph 3.107 .", "target_text": "The members approval of bonus payments is required as part of the Merger Resolutions (see section 96(4) to (6) of the 1986 Act) and see paragraph 3.59 for the PRA’s view of what may constitute a bonus). If the total gross cost of the proposed bonus(es) (ie without any adjustment for prospective corporation tax recovery) is within the prescribed limit, then approval for it need only be included in each of the Merger Resolutions of the society whose funds are to be distributed. If it exceeds that limit then it must be included in each of the Merger Resolutions of each participating society. The prescribed limit was changed by the Building Societies (Mergers) (Amendment) Regulations SI 1995/1874 amending S1 1987/2005 and now is:", "source_passage_id": "64a6d4e1a3eca833", "target_passage_id": "9dfe512afd4bf0e8", "method": "DPEL", "persona": "professional"}
{"item_id": "04fea2f0f9b090ba", "question": "In a transfer to a specially formed successor company, how must the terms of the transfer address the society’s holding of shares by the time the society dissolves, and how does that requirement interact with the society’s ability to notify a later dissolution date in its vesting-date notice (including any limits on business activity after the vesting date)?", "gold_answer": "The transfer documentation must be drafted so that it ensures the society will no longer hold any shares in the specially formed successor company by the date on which the society is to dissolve. [#SRC:6b46a0ab65f37c08] In parallel, once the PRA has confirmed the transfer it will notify the FCA and the society, and the society must itself notify the PRA and the FCA of the vesting date no later than seven days before that date. [#TGT:44f3b2962ff383a8] Unless the society gives a notice that specifies a later dissolution date, the society is dissolved on the vesting date; however, if it is necessary to facilitate disposal of the society’s shares in its successor, the society may include in the vesting-date notice a later dissolution date, and dissolution then occurs on that later date. [#TGT:44f3b2962ff383a8] The share-disposal linkage is that the transfer terms must still secure that the society ceases to hold any shares by the (possibly later) dissolution date identified through this notice mechanism. [#SRC:6b46a0ab65f37c08] If the society uses the later-dissolution option, it must stop transacting business from the notified vesting date, except business needed to dispose of its shares in its successor. [#TGT:44f3b2962ff383a8]", "source_text": "The terms of the transfer must include provision to secure that the society ceases to hold any shares in the specially formed successor company by the date on which the society is to dissolve (Section 100(11) of the 1986 Act). The provisions of the 1986 Act concerning the dissolution of the society and the disposal of any shares in its successor are discussed in section ‘ Notification and Dissolution ’.", "target_text": "When the PRA has confirmed a transfer (whether voluntary or under direction) it will notify the FCA and the society concerned. Section 97(8) of the 1986 Act requires the society to notify the PRA and the FCA of the vesting date, and it must do so no later than seven days before that date, and, unless a notice is given under subsection (10), subsection (9) provides that the society shall be dissolved on that date. Subsection (10) provides that, if necessary for the purpose of facilitating the disposal of its shares in its successor, the society may include, in the notice of the vesting date, notice of a later date for the dissolution of the society, and it is on this later date that the society is dissolved. A society which gives such a notice must cease to transact any business as from the notified vesting date, except such as may be necessary to dispose of its shares in its successor.", "source_passage_id": "6b46a0ab65f37c08", "target_passage_id": "44f3b2962ff383a8", "method": "DPEL", "persona": "professional"}
{"item_id": "7b671dfbef3dec21", "question": "When 2.1(1) or 2.1(2) applies so that specified requirements must be applied “with any necessary changes” at the level of the group, how should a firm ensure its risk-management system addresses risks both individually and on an aggregated basis, and which referenced requirement set is being applied at group level to support that outcome?", "gold_answer": "If 2.1(1) or 2.1(2) applies, the firm must apply the listed requirement sets “with any necessary changes” at the level of the group, meaning the firm should treat those requirements as operating on a group-wide basis rather than only on a solo-entity basis. [#SRC:bb599b0cccb14552] In that group-level context, the firm’s risk-management system must be designed and maintained so it can identify, measure, monitor, manage, and report risks continuously both for each relevant unit (individual level) and across the group as a whole (aggregated level), including how risks interact with each other (interdependencies). [#TGT:9f2e6ec1c2bc29ca] Practically, this means the group-level application should be used to ensure the risk-management system includes strategies, processes, and reporting procedures that work across the group and can produce both entity-specific and consolidated risk views on an ongoing basis. [#TGT:9f2e6ec1c2bc29ca] The referenced requirement sets that are expressly to be applied at group level include, among others, Conditions Governing Business (including 2.2 to 2.6 and 2A.1 to 2A.6), Fitness and Propriety (including 2.1 to 2.3, 4.1, 4.3 and 4.4), Allocation of Responsibilities 4, and Key Function Holder – Notifications 2 to 6 (in accordance with 17.4). [#SRC:bb599b0cccb14552]", "source_text": "(1) Where 2.1(1) or 2.1(2) applies, the following requirements apply with any necessary changes at the level of the group : (1a) Conditions Governing Business 1A ; (a) Conditions Governing Business 2.2 to 2.6 ; (a1) Conditions Governing Business 2A.1 to 2A.6 ; (b) Conditions Governing Business 3 ; (b1) Conditions Governing Business 3A ; (c) Conditions Governing Business 4 ; (c1) Conditions Governing Business 4A ; (d) Conditions Governing Business 5 ; (e) Conditions Governing Business 6 ; (f) Conditions Governing Business 7 ; (f1) Conditions Governing Business 11A to 11F ; (g) Fitness and Propriety 2.1 to 2.3 , 4.1 , 4.3 and 4.4 ; (h) Allocation of Responsibilities 4 ; and (i) Key Function Holder – Notifications 2 to 6 , in accordance with 17.4 .", "target_text": "(1) A firm must establish, implement, and maintain an effective risk-management system comprising strategies, processes and reporting procedures necessary to identify, measure, monitor, manage and report on a continuous basis the risks, at an individual and at an aggregated level, to which it is or could be exposed, and their interdependencies.", "source_passage_id": "bb599b0cccb14552", "target_passage_id": "9f2e6ec1c2bc29ca", "method": "DPEL", "persona": "professional"}
{"item_id": "9d6615964b52a6d5", "question": "For a UK subsidiary of a group based outside of the UK, how should the recovery plan describe (i) the UK governance framework for monitoring indicators and taking action, including when decisions are escalated to group level, and (ii) the SMR accountability arrangements for recovery planning, including the named executive’s responsibilities for the recovery plan and resolution pack and engagement with the PRA?", "gold_answer": "A UK subsidiary of a group based outside of the UK should set out a UK-specific governance framework that explains how indicators are monitored and how actions are triggered, and it should also specify the point at which decisions are escalated to group level. [#SRC:540b8d2e62cc1fe2] In parallel, because recovery planning is treated as a prescribed responsibility under the SMR, the firm should identify a named executive who is accountable for the recovery plan and resolution pack and who oversees the internal governance processes supporting them. [#TGT:084062e615cc02e8] The accountable executive director should be clearly identified as responsible for the recovery plan and for serving as the firm’s contact point with the authorities on recovery plan matters. [#TGT:084062e615cc02e8] The PRA’s expectations for this accountable person include being answerable for the quality of the recovery plan, ensuring it is structured to be usable by senior executives and board members in a stress, driving improvements (including in response to PRA feedback), and managing the firm’s engagement with the PRA on recovery planning issues. [#TGT:084062e615cc02e8] For UK subsidiaries of non-UK groups, the plan should also reflect the PRA’s expectation that the subsidiary meets relevant SMR-related requirements referenced for such firms, aligning the UK governance framework and escalation arrangements with clearly assigned responsibilities under the SMR. [#SRC:540b8d2e62cc1fe2]", "source_text": "(vi) The plan should include a UK governance framework for monitoring the indicators and taking action where appropriate. For UK subsidiaries of groups based outside of the UK, in meeting expectations set out in Chapter 2 (viii) , the PRA expects firms to set out when decisions would be escalated to group level. In addition, the PRA expects UK subsidiaries of groups based outside of the UK to meet requirements set out in Chapter 2 (xiii) (c) in relation to responsibilities under the SMR.", "target_text": "Firms are reminded that recovery planning is a prescribed responsibility under the SMR which means that there should be a named executive at each firm that is accountable for the recovery plan and resolution pack and for overseeing the internal processes regarding their governance. 18 Firms should identify the accountable executive director responsible for the firm’s recovery plan and for acting as the firm’s contact point with the authorities on its recovery plan. The PRA has observed that this is typically the CEO, CFO or CRO. The PRA will hold this person accountable for the quality of the recovery plan, for the plan being structured so as to be usable by senior executives and board members in a stress, for making improvements to the recovery plan (including in response to the PRA’s feedback) and for the firm’s engagement with the PRA on recovery planning issues.", "source_passage_id": "540b8d2e62cc1fe2", "target_passage_id": "084062e615cc02e8", "method": "DPEL", "persona": "professional"}
{"item_id": "012dac127037d5ef", "question": "At the point of initial investment, if a firm cannot develop a robust methodology for the addition to the FS due to data scarcity, how should it reconcile proposing a simpler (standard) methodology with the expectation to model a term structure, and what demonstration is needed to justify using a uniform allowance instead?", "gold_answer": "A firm that cannot build a robust methodology for the addition to the FS at the point of initial investment (for example because of data scarcity) may propose a simpler (standard) methodology for calculating the FS, but it should still treat term-structure modelling as the default expectation unless it can justify a uniform allowance. [#SRC:43891e9059ef7894] [#TGT:479d238324e3667c] In practice, the firm can start with a standard approach (and include safeguards aimed at protecting the quality of matching), while assessing whether it can meet the conditions for not modelling a term structure. [#SRC:43891e9059ef7894] [#TGT:479d238324e3667c] To rely on a uniform allowance rather than modelling a term structure for the addition to the FS, the firm needs to be able to demonstrate two points: (1) that using a uniform allowance would not materially affect the adequacy of the allowance for risks arising from cash flow uncertainty, and (2) that it would not materially affect either the assessment of the quality of asset and liability cash flow matching or the results of the PRA’s Matching Tests. [#TGT:479d238324e3667c] Where the firm proceeds with a standard methodology due to initial-investment constraints, the PRA indicates it does not necessarily expect the firm to go beyond a standard methodology to model a term structure as referenced in the earlier paragraph, but the firm must still align its approach with the term-structure expectation or the uniform-allowance demonstration. [#SRC:43891e9059ef7894] [#TGT:479d238324e3667c]", "source_text": "The PRA understands that, at the point of initial investment, in many cases it may not be possible to develop a robust methodology for the addition to the FS, for example due to data scarcity. Firms may therefore propose a simpler (standard) methodology for calculating the FS, together with any safeguards that could mitigate the risks to the quality of matching. The PRA does not necessarily expect a firm to go beyond a standard methodology to model a term structure as set out in paragraph 5.21 above.", "target_text": "Firms should model a term structure for the addition to the FS unless it can be demonstrated that a uniform allowance would not materially affect the adequacy of the allowance for the risks arising from cash flow uncertainty, and that a uniform allowance would not materially affect the assessment of the quality of asset and liability cash flow matching or the results of the PRA’s Matching Tests.", "source_passage_id": "43891e9059ef7894", "target_passage_id": "479d238324e3667c", "method": "DPEL", "persona": "professional"}
{"item_id": "068275bbddad09b9", "question": "When a TWD firm writes its recovery plan, what does it need to say about the TWD option (including the active and passive wind-down periods and the cost/capital/liquidity impacts), and how do the firm’s TWD capabilities fit in for carrying out the recovery plan and BRP in real-life situations?", "gold_answer": "In its recovery plan, a TWD firm should describe the TWD option in a way that makes it easy to carry out in a stress, and it should back that plan with TWD capabilities that let it develop and execute the option in real-life circumstances, including for the BRP. [#SRC:e73d3db81c430c67] [#TGT:896c93bcd423e6b8] The plan should explain the TWD option and, where relevant, include the playbook so implementation in stress is straightforward. [#SRC:e73d3db81c430c67] The plan should also quantify the costs of the wind-down and set out the impacts on the TWD firm’s projected capital and liquidity resources across the wind-down period, which runs from the moment the TWD option is executed until the firm’s trading activities have been wound down. [#SRC:e73d3db81c430c67] For clarity and execution, the wind-down period should be split into: (1) an active wind-down period, ending when the firm has exited all positions it can exit without undue costs; and (2) a passive wind-down period, when the firm hedges exposures of remaining rump positions where possible until they expire. [#SRC:e73d3db81c430c67] Separately, the firm should maintain TWD capabilities that enable it to develop and execute the TWD option in a variety of real-life circumstances, and it should use those capabilities to help develop and execute both its recovery plan and its BRP. [#TGT:896c93bcd423e6b8]", "source_text": "The TWD option should be explained in the TWD firm’s recovery plan, including the playbook where relevant, such that the TWD option would be easily implemented in a stress. The quantification of the costs of the wind-down, set out in more detail in Chapter 4 , and any impacts on the TWD firm’s projected capital and liquidity resources throughout the period from the time at which the TWD option is executed to the time at which the TWD firm’s trading activities have been wound down (hereinafter referred to as the ‘wind-down period’), should also be set out in the TWD firm’s recovery plan. 14 The wind-down period can be split into the period from the time at which the TWD option is executed to the time at which the TWD firm has exited all the positions it can exit without incurring undue costs (hereinafter referred to as the ‘active wind-down period’); and the rest of the wind-down period, during which the firm hedges the exposures of the remaining ‘rump’ positions (insofar as this is possible) until they expire (hereinafter referred to as the ‘passive wind-down period’).", "target_text": "TWD firms should have TWD capabilities that will enable them to develop and execute the TWD option in a variety of real-life circumstances. TWD firms should use their TWD capabilities to help them to develop and execute their recovery plan and BRP.", "source_passage_id": "e73d3db81c430c67", "target_passage_id": "896c93bcd423e6b8", "method": "DPEL", "persona": "basic"}
{"item_id": "d75493d4acc28b46", "question": "When assessing the operational resilience of the firm and group, how should the firm treat risks arising elsewhere in the group (including intragroup outsourcing or other inter-affiliate arrangements) in relation to its ability to deliver “important business services” versus “critical operations,” and which UK entity types are those two service concepts tied to?", "gold_answer": "In assessing operational resilience, the firm should explicitly consider how risks originating elsewhere in the group—including those created or transmitted through intragroup outsourcing or other inter-affiliate arrangements—could impair the firm’s ability to continue delivering the services that matter most, and it should map that assessment to the correct service concept based on the relevant UK entity type. [#SRC:2799da281c0d7ac4] “Important business services” should be treated as the category of services defined in the Operational Continuity Part of the PRA Rulebook, and this framing applies to CRR firms, described here as UK subsidiaries of international groups. [#TGT:083adfa9d1ebdfbf] “Critical operations” should be treated as the category of services defined in the Basel Committee on Banking Supervision’s Principles for Operational Resilience (March 2021), and this framing is relevant for UK branches. [#TGT:083adfa9d1ebdfbf] Practically, the firm’s group-risk analysis should therefore: (i) identify group-originated risks that could disrupt delivery; (ii) include dependencies created by intragroup outsourcing and inter-affiliate arrangements; and (iii) classify the impacted services as “important business services” for CRR firms (UK subsidiaries) or as “critical operations” for UK branches, so the resilience assessment is aligned to the applicable service definition. [#SRC:2799da281c0d7ac4] [#TGT:083adfa9d1ebdfbf]", "source_text": "the operational resilience of the firm and group, including risks arising elsewhere in the group that may affect the ability of the firm to deliver its important business services or critical operations (such as those provided through intragroup outsourcing or other inter-affiliate arrangements); 25", "target_text": "25. Important business services refers to services as defined in the Operational Continuity Part of the PRA Rulebook which applies to CRR firms – ie UK subsidiaries of international groups. Critical operations refers to services as defined in the Basel Committee on Banking Supervision’s ‘Principles for Operational Resilience’ (March 2021): https://www.bis.org/bcbs/publ/d516.pdf , and is relevant for UK branches.", "source_passage_id": "2799da281c0d7ac4", "target_passage_id": "083adfa9d1ebdfbf", "method": "DPEL", "persona": "professional"}
{"item_id": "665d75f4706134f2", "question": "If a firm is allowed to use a partial or full internal model, what does it have to send the PRA every quarter about model changes, and which template and instructions tell it what to include (including qualitative support)?", "gold_answer": "If a firm has permission to use a partial or full internal model, it has to send the PRA a quarterly update about changes to that model. [#SRC:6b80f0d656b136bd] The quarterly update must be a summary that covers both minor and major model changes, and it is required under Article 6(3) of Chapter 2A of the Reporting Part of the PRA Rulebook together with the EIOPA Guidelines on the use of internal models. [#SRC:6b80f0d656b136bd] To provide the information in the required reporting format, firms using an internal model must submit quarterly template QMC.01 in Chapter 9. [#TGT:96395cb1453e2aa2] That template is used to specify information on model changes and to include supporting qualitative information, so the quarterly summary is not just a list of changes but also includes qualitative support. [#TGT:96395cb1453e2aa2] The firm must also follow the instructions in section QMC.01 of Chapter 10, which sets out how to complete the template and what information to provide. [#TGT:96395cb1453e2aa2] In practice, the firm meets the quarterly summary requirement by completing and submitting QMC.01 with the required model-change details and qualitative support to the PRA each quarter. [#SRC:6b80f0d656b136bd] [#TGT:96395cb1453e2aa2]", "source_text": "In accordance with Article 6(3) of Chapter 2A of the Reporting Part of the PRA Rulebook and the EIOPA Guidelines on the use of internal models, firms with permission to use a partial or full internal model are required to provide a quarterly summary of minor and major model changes to the PRA.", "target_text": "Firms using an internal model must submit to the PRA quarterly template QMC.01 of Chapter 9 , specifying information on model changes and supporting qualitative information, in accordance with the instructions set out in section QMC.01 of Chapter 10 .", "source_passage_id": "6b80f0d656b136bd", "target_passage_id": "96395cb1453e2aa2", "method": "DPEL", "persona": "basic"}
{"item_id": "01b4f46861e79a5c", "question": "If the C17.01/C17.02 reporting instructions tell you to use supervisory disclosures from the EBA website, what UK document should you use instead, and where do you find it online?", "gold_answer": "You should treat the instruction to use supervisory disclosures from the EBA website as meaning you must use the corresponding disclosure produced by the PRA for those COREP templates. [#SRC:40ad42a86de28e1d] The online location for that PRA disclosure is the “Regulatory reporting – banking sector” page in the prudential regulation section of the Bank of England website, using the specific web address provided. [#TGT:91473ca52a070954] This linkage matters because the COREP instructions for C17.01 and C17.02 explicitly redirect certain non-UK references (including the EBA supervisory disclosure reference) to UK equivalents, so your reporting should be based on the PRA-produced disclosure rather than the EBA publication. [#SRC:40ad42a86de28e1d] In other words, when you see the EBA supervisory disclosure reference in those instructions, you should navigate to the Bank of England prudential regulation area and retrieve the PRA disclosure from the Regulatory reporting – banking sector page, ensuring your template completion uses the UK-referenced source. [#TGT:91473ca52a070954]", "source_text": "Example occurrences: The CRR COREP instructions for C17.01 and C17.02 (Annexes I and II of PRA Rulebook, Reporting (CRR) Part, Templates and Instructions) contain references to supervisory disclosures published on the EBA website, and the gross domestic product at market prices data published by Eurostat. These references should be read as a reference to the corresponding disclosure produced by the PRA, 4 and the corresponding data published by the Office for National Statistics. The instructions for Solvency II templates S06.02, S08.01, S30.02, S30.04, S31.01, S31.02 and S37.01 include a list of credit rating agencies as registered or certified by the European Securities and Markets Authority (ESMA). This should be read as a reference to the list of credit rating agencies as registered or certified within the UK.", "target_text": "4. This can be found on the Regulatory reporting – banking sector page in the prudential regulation section of the Bank of England website: http://www.bankofengland.co.uk/prudential-regulation/regulatory-reporting/regulatory-reporting-banking-sector .", "source_passage_id": "40ad42a86de28e1d", "target_passage_id": "91473ca52a070954", "method": "DPEL", "persona": "basic"}
{"item_id": "af079351616475bf", "question": "If a firm is setting up its risk-management system, what does it need to cover so it both (a) includes risks used for the SCR and risks not fully captured there, and (b) meets the requirement that calibration takes account of all quantifiable risks (including the listed minimum risk types)?", "gold_answer": "The firm needs a risk-management system that is broad enough to cover the risks used in the SCR calculation and also any risks that are not, or not fully, included in that calculation, while also aligning with the calibration expectation that all quantifiable risks the firm faces are taken into account. [#SRC:ec68cf68d094e876] [#TGT:f261181a95a3ca51] The system must be effective and properly integrated into the firm’s organisational structure and decision-making processes, with proper consideration of the persons who have key functions, so that the calibration and risk coverage are embedded in how the firm is run. [#SRC:ec68cf68d094e876] To make this concrete, the calibration requirement says quantifiable risks must be captured and names at least non-life underwriting risk, life underwriting risk, health underwriting risk, market risk, credit risk, and operational risk. [#TGT:f261181a95a3ca51] The risk-management system must also cover at least these areas: underwriting and reserving; asset-liability management; investment risk management (especially derivatives, quasi-derivatives and similar commitments); liquidity risk and concentration risk management; operational risk management; and reinsurance and other risk-mitigation techniques. [#SRC:ec68cf68d094e876] Putting these together, the firm should ensure its listed risk-management areas are used to identify and manage the minimum risk categories and any other quantifiable risks, including those not fully reflected in the SCR calculation. [#SRC:ec68cf68d094e876] [#TGT:f261181a95a3ca51]", "source_text": "(2) That risk-management system must: (a) be effective and well integrated into the organisational structure and decision-making processes of the firm with proper consideration of the persons who have key functions ; (b) cover the risks to be included in the calculation of the SCR as set out in Solvency Capital Requirement - General Provisions 3.3(1) , as well as the risks which are not, or not fully, included in the calculation thereof; and (c) cover at least the following areas: (i) underwriting and reserving as set out in 3.1A(1) ; (ii) asset-liability management as set out in 3.1A(2) ; (iii) investment risk management, in particular derivatives , quasi-derivatives and similar commitments, as set out in 3.1A(3) ; (iv) liquidity risk and concentration risk management: as set out in 3.1A(4) and 3.1A(5) ; (v) operational risk management as set out in 3.1A(6) ; and (vi) reinsurance and other risk-mitigation techniques as set out in 3.1A(7) .", "target_text": "(1) must be calibrated to ensure that all quantifiable risks to which the firm is exposed are taken into account, including at least the non-life underwriting risk , life underwriting risk , health underwriting risk , market risk , credit risk , and operational risk ;", "source_passage_id": "ec68cf68d094e876", "target_passage_id": "f261181a95a3ca51", "method": "DPEL", "persona": "basic"}
{"item_id": "5092e2bd1a5462e5", "question": "What does the text say non-executive directors must do (including what “independence of mind” looks like in board decisions), and where is the related EU law reference shown (Article 91(8) of the Capital Requirements Directive 2013/36/EU)?", "gold_answer": "The text says that all non-executive directors who are members of the management body—whether independent or not—have a binding obligation to act with honesty, integrity, and independence of mind. [#SRC:8e63907640d17c50] It also clarifies that “independence of mind” is not just a label but a pattern of behaviour that shows up especially during board discussions and decision-making, where each board member should be able to reach sound, objective, and independent decisions and judgements. [#SRC:8e63907640d17c50] Alongside that, the same passage ties these expectations to specified internal conduct requirements by stating that non-executive directors are required under Rules 2.1–2.3 and 3.4 in the Conduct Rules Part of the Rulebook to act with integrity, due skill, care and diligence, and to be open and co-operative with regulators. [#SRC:8e63907640d17c50] The related EU law reference is shown separately as a citation to “Article 91(8) Capital Requirements Directive (2013/36/EU),” including a link to the legislation source, which is the explicit place where the EU provision is identified in the provided materials. [#TGT:f668b599884eb746]", "source_text": "As members of the management body, all non-executive directors, whether independent or not, have a binding obligation to act with honesty, integrity and independence of mind 53 and are required under Rules 2.1 - 2.3 and 3.4 in the Conduct Rules Part of the Rulebook to act with integrity, due skill, care and diligence and to be open and co-operative with regulators 54 . Independence of mind is a pattern of behaviour, shown in particular during discussions and decision making at the board. All members of the board should be able to make their own sound, objective and independent decisions and judgements. 55 Banks should consider the appropriate number of non-executive directors who are significant shareholders or who are appointed or nominated by a significant shareholder.", "target_text": "53. Article 91(8) Capital Requirements Directive (2013/36/EU): https://www.legislation.gov.uk/eudr/2013/36/article/91 .", "source_passage_id": "8e63907640d17c50", "target_passage_id": "f668b599884eb746", "method": "DPEL", "persona": "basic"}
